[go: up one dir, main page]

WO2021132764A1 - Method for separating and purifying fucoxanthin from diatoms - Google Patents

Method for separating and purifying fucoxanthin from diatoms Download PDF

Info

Publication number
WO2021132764A1
WO2021132764A1 PCT/KR2019/018529 KR2019018529W WO2021132764A1 WO 2021132764 A1 WO2021132764 A1 WO 2021132764A1 KR 2019018529 W KR2019018529 W KR 2019018529W WO 2021132764 A1 WO2021132764 A1 WO 2021132764A1
Authority
WO
WIPO (PCT)
Prior art keywords
fucoxanthin
diatoms
separating
purifying
diatom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2019/018529
Other languages
French (fr)
Korean (ko)
Inventor
๊ณ ๊ฒฝ๋ฏผ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jnc Bio Fisheries Co Ltd
Original Assignee
Jnc Bio Fisheries Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jnc Bio Fisheries Co Ltd filed Critical Jnc Bio Fisheries Co Ltd
Publication of WO2021132764A1 publication Critical patent/WO2021132764A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D301/00Preparation of oxiranes
    • C07D301/32Separation; Purification
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/336Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/32Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by aldehydo- or ketonic radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/805Corresponding aspects not provided for by any of codes A61K2800/81ย -ย A61K2800/95

Definitions

  • the present invention relates to a method for separating and purifying diatom-derived fucoxanthin, and more particularly, to an optimal method for separating and purifying fucoxanthin from adherent diatoms taken together with Jeju lava seawater.
  • Lava seawater is seawater that penetrates the basalt layer of Jeju Island and flows underground.
  • Lava seawater is found mainly in the western and eastern parts of Jeju Island and contains high concentrations of minerals.
  • general seawater is exposed to unstable environments such as domestic sewage, industrial wastewater, and port pollution, it takes a lot of money to process industrial materials, whereas lava seawater undergoes natural purification and filtration by volcanic bedrock to block heavy metal adsorption and harmful substances. Therefore, it secures safety, stability, and economic feasibility, and the cost of water intake is incomparably lower than that of deep sea water taken from the deep sea.
  • Adherent diatoms can be used as a valuable resource as an alternative energy source for feed in the aquaculture industry or as a basic material in various industrial fields such as medicine, environment, and life industry.
  • the carotenoid market is classified into synthetic carotenoids and carotenoids derived from natural products, and is growing steadily.
  • the global carotenoid market was valued at USD 1.5 billion in 2014 and is expected to increase to approximately USD 1.8 billion in 2019.
  • xanthophyll-based carotenoids such as lutein, canthaxanthin, and astaxanthin is increasing, and they are mainly used as natural pigments, antioxidants, vitamin A precursors, and aquaculture feed additives.
  • Fucoxanthin refers to a kind of carotenoid pigment that is mainly present in brown algae such as seaweed, kelp, motherwort, and turmeric. Brown algae are brown because their unique photosynthetic pigment called fucoxanthin is relatively higher than that of chlorophyll. It assists photosynthesis by capturing light energy and delivering about 80% of it to chlorophyll. The captured light energy absorbs light with a wavelength of 450 to 540 nm on the spectrum, and absorbs the most light with a wavelength of 510 to 525 nm, and is known to have various effects such as anti-obesity, anti-inflammatory, skin protection, and anti-aging.
  • (S1) agitating the diatoms collected by mass culture in 70% alcohol; (S2) loading and filtering on a filter bed pre-coated with diatomaceous earth; (S3) fractionating and concentrating the filtered extract; (S4) separating and purifying fucoxanthin from the concentrated extract; And (S5) provides a separation and purification method of diatom-derived fucoxanthin comprising the step of storing the separated and purified fucoxanthin in a dark room.
  • the diatoms may be adherent diatoms that are taken together with Jeju lava seawater.
  • the adherent diatoms are Melosira nummuloides, Achnanthes brevipes var. It may be at least one species selected from the group consisting of intermedia, Achnanthes sancti-pauli, Achnanthes brevipes, or Melosira octogona.
  • the diatoms may be diatoms collected from a bottom diatom culture.
  • step (S1) may be characterized in that it is treated with an alcohol amount of 7 times (v/v) compared to the raw material for 1 day.
  • step (S1) it may further include the step of treating plasma for 25 minutes in step (S1).
  • (S4) the step of separating and purifying fucoxanthin from the concentrated extract may be characterized in that it is performed by silica gel column chromatography.
  • the elution solvent used for the silica gel column chromatography may be characterized in that the ratio of N-hexane to acetone is 7:3.
  • the present invention provides an optimal method for separating and purifying fucoxanthin from adherent diatoms taken from lava seawater in Jeju, Korea. Using high-purity fucoxanthin separated and purified from adherent diatoms cultured in large quantities, medical and cosmetic It can be used in various industrial fields such as fields.
  • 1 is a standard solution 1 in which the raw material of diatomaceous material is stirred in alcohol, loaded on a filter bed pre-coated with diatomaceous earth and filtered, and fucoxanthin purified by silica gel column chromatography is dissolved in methanol. HPLC analysis for
  • Figure 2 is HPLC for the mother liquid of standard solution 2, in which the raw material of diatomaceous material was stirred in alcohol, loaded on a filter bed pre-coated with diatomaceous earth, filtered, and stored at -20ยฐC for two days for recrystallization. analysis is shown.
  • Figure 3 is HPLC for the crystallization of standard solution 2, in which the raw material of diatomaceous material is stirred in alcohol, loaded on a filter bed pre-coated with diatomaceous earth, filtered, and stored at -20ยฐC for two days for recrystallization. analysis is shown.
  • Figure 4 shows the HPLC analysis of the standard solution 3 prepared in the same manner as the standard solution 1, but without the desalting reaction.
  • Figure 5 shows the HPLC analysis of the standard solution 3 prepared in the same manner as the standard solution 1, but subjected to a desalting reaction.
  • Figure 10 shows a schematic diagram of the fucoxanthin separation and purification process.
  • Figure 11 shows the fucoxanthin separation and purification process by silica gel column chromatography (silica gel column chromatography).
  • Figure 12 shows the results of TLC (Thin Layer Chromatography) of the fraction containing fucoxanthin.
  • Figure 19 shows the HPLC quantitative analysis of Sample No 1 of Table 3.
  • Figure 21 shows the HPLC quantitative analysis of Sample No 15 of Table 3.
  • Figure 22 shows the HPLC quantitative analysis of Sample No 16 of Table 3.
  • Figure 24 shows the HPLC quantitative analysis of Sample No 8 of Table 3.
  • (S1) agitating the diatoms collected by mass culture in 70% alcohol; (S2) loading and filtering on a filter bed pre-coated with diatomaceous earth; (S3) fractionating and concentrating the filtered extract; (S4) separating and purifying fucoxanthin from the concentrated extract; And (S5) provides a separation and purification method of diatom-derived fucoxanthin comprising the step of storing the separated and purified fucoxanthin in a dark room.
  • the diatoms may be adherent diatoms that are taken together with Jeju lava seawater.
  • the adherent diatom is Melosira nummuloides, Achnanthes brevipes var. It may be at least one species selected from the group consisting of intermedia, Achnanthes sancti-pauli, Achnanthes brevipes, or Melosira octogona.
  • the diatoms may be diatoms collected from a bottom diatom culture.
  • step (S1) may be characterized in that it is treated with an alcohol amount of 7 times (v/v) compared to the raw material for 1 day.
  • it may further include the step of treating plasma for 25 minutes in step (S1).
  • the step of separating and purifying fucoxanthin from the concentrated extract may be characterized in that it is performed by silica gel column chromatography.
  • the elution solvent used for the silica gel column chromatography may be characterized in that the ratio of N-hexane to acetone is 7:3.
  • the separation and purification method was optimized by measuring the change in the content of fucoxanthin according to the separation and purification method. To this end, 50 g of diatoms in wet state were first put and dried in a vacuum dryer for 48 hours, and thereafter, the change in the content of fucoxanthin by various processes was measured using HPLC.
  • standard solution 2 was prepared through a recrystallization process. Dissolving a solute in a solvent at a higher temperature can dissolve a larger amount of the solute than at a lower temperature. In this dissolved state, if the temperature is lowered again slowly, the solubility decreases, so the solute is precipitated again to form crystals, which is called recrystallization.
  • the filtered sample for recrystallization experiment was stored at -20ยฐC for two days to prepare standard solution 2. After that, standard solution 2 was dispensed in a transparent container and the content of fucoxanthin was measured by HPLC.
  • Standard solution 3 proceeded in the same manner as standard solution 1 except for adding the desalting process for raw diatoms, and the effect of the desalting process was verified.
  • Standard solution 3 was dispensed in a transparent container and the content of fucoxanthin was measured by HPLC. There was no color change and fucoxanthin content was calculated based on the peak area value. The observed fucoxanthin content was lowered to a level of 21% compared to standard solution 1 when desalting was performed, and was lowered to a level of 17% when desalting was not performed ( FIGS. 4 and 5 ).
  • Standard solution 4 verified the stability of fucoxanthin by changing the content of fucoxanthin when exposed to sunlight.
  • Standard solution 4 was dispensed in a transparent container and the content of fucoxanthin was measured by HPLC. There was no color change and fucoxanthin content was calculated based on the peak area value.
  • the content decreased by about 82%, and the purity decreased from 90% to 55% (FIG. 6).
  • Silica gel chromatography is used for separation and purification of functional substances such as fucoxanthin. will be.
  • silica gel chromatography was performed under various conditions to efficiently separate and purify fucoxanthin, a target material.
  • the primary alcohol extract obtained by first filtering the extract extracted from 100 g of diatom powder with 70% alcohol at 10 times the volume with 5um filter paper was separated into n-Hexane: 70% alcohol (1:1), and 70% alcohol in the lower layer A fraction was obtained.
  • a fraction (dark orange layer) that is expected to contain fucoxanthin was obtained and TLC (Thin Layer Chromatography) was performed (FIGS. 11 and 12), and as a result, fractions from Fraction No. 1 to No. 9 It was confirmed that fucoxanthin was separated from the , and the concentration process was performed using a high pressure vacuum concentrator (FIG. 13).
  • the standard material fucoxanthin (purchased from Sigma Aldrich) was diluted by concentration to prepare an HPLC standard calibration curve (FIG. 14).
  • HPLC standard calibration curve For HPLC analysis, Waters 2695 HPLC equipment was used, the column used was Kromasil 100-5-C18 (4.6x250mm, 5um), the detection wavelength was 450 nm, and the solvent was Acetonitrile / water (Table 2).
  • the usefulness of recrystallization of the concentrate to improve the degree of purification and yield of fucoxanthin was studied. Specifically, the primary extract obtained by stirring 100 g of diatomaceous powder with 70% alcohol at 10 times the volume for 2 hours was loaded into a filter bed coated with 50 g of diatomaceous earth to obtain an extract filtrate. The finally obtained concentrate was dissolved in acetone, and the fucoxanthin fraction was sampled by silica gel chromatography, and it was checked by TLC (Thin Layer Chromatography) to confirm that the fucoxanthin was separated (FIG. 16).
  • TLC Thin Layer Chromatography
  • HPLC analysis was performed under the same conditions as in Example, and dry diatom powder (No. 1 to No. 11) was dissolved in methanol at a concentration of 50 mg/mL, sonicated for 30 minutes, filtered, and then used for analysis. This was repeated 3 times.
  • the bottom diatom showed a higher fucoxanthin content than the floating diatom (Table 3, No. 1 & No. 3), and the presence or absence of desalination did not significantly affect the content change. appear.
  • the diatomite sample that had the highest content of fucoxanthin was an undried diatomite sample. This result indicates that some of the fucoxanthin in the diatom was decomposed during the collection and drying (natural drying or hot air drying) process of the diatom culture ( No. 15, 16).
  • the harvesting/processing step of diatom it is the most efficient process to directly harvest the raw diatom without going through the drying process and directly enter the extraction process.
  • the optimal extraction conditions were determined by comparing and analyzing the extraction efficiency of fucoxanthin according to the presence or absence of plasma treatment.
  • extracts were prepared from samples treated with plasma and untreated biodiatoms to compare the extraction yield of fucoxanthin. After adding 20 mL of 70% alcohol to 5 g of biological diatom, plasma was treated for 25 minutes, extracted at 40 ยฐ C for 3 days, the extract was centrifuged at 3500 rpm for 10 minutes to remove the extraction residue, and HPLC analysis was performed using the extract of the upper layer. As a control, a sample that was not subjected to plasma treatment under the same extraction conditions as above was set as a control. Since the extract was small, the extract was obtained after removing the residue by centrifugation without going through a filtration process (Table 4), and the fucoxanthin extraction efficiency according to plasma treatment was reviewed through HPLC analysis (Table 5).
  • the optimal extraction conditions were determined by comparatively analyzing the extraction efficiency according to the type of solvent used, the amount of solvent, and the extraction time.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Epoxy Compounds (AREA)

Abstract

The present invention relates to a method for separating and purifying fucoxanthin from diatoms, and provides the optimal method for separating and purifying fucoxanthin from adhesive diatoms collected from Yong Am sea water on the South Korean island of Jeju. Highly pure fucoxanthin, separated and purified from the adhesive diatoms cultured at a large scale, can be used and applied in a variety of industrial fields such as medicine and cosmetics.

Description

๊ทœ์กฐ๋ฅ˜ ์œ ๋ž˜ ํ›„์ฝ”์ž”ํ‹ด์˜ ๋ถ„๋ฆฌ์ •์ œ๋ฐฉ๋ฒ•Separation and purification method of fucoxanthin derived from diatoms

๋ณธ ๋ฐœ๋ช…์€ ๊ทœ์กฐ๋ฅ˜ ์œ ๋ž˜ ํ›„์ฝ”์ž”ํ‹ด์˜ ๋ถ„๋ฆฌ์ •์ œ๋ฐฉ๋ฒ•์— ๊ด€ํ•œ ๊ฒƒ์œผ๋กœ, ๋”์šฑ ์ƒ์„ธํ•˜๊ฒŒ๋Š” ์ œ์ฃผ ์šฉ์•” ํ•ด์ˆ˜์™€ ํ•จ๊ป˜ ์ทจ์ˆ˜๋˜๋Š” ๋ถ€์ฐฉ์„ฑ ๊ทœ์กฐ๋ฅ˜๋กœ๋ถ€ํ„ฐ ํ›„์ฝ”์ž”ํ‹ด์„ ๋ถ„๋ฆฌ์ •์ œํ•˜๋Š” ์ตœ์ ์˜ ๋ฐฉ๋ฒ•์— ๊ด€ํ•œ ๊ฒƒ์ด๋‹ค.The present invention relates to a method for separating and purifying diatom-derived fucoxanthin, and more particularly, to an optimal method for separating and purifying fucoxanthin from adherent diatoms taken together with Jeju lava seawater.

์šฉ์•”ํ•ด์ˆ˜๋ž€ ์ œ์ฃผ๋„์˜ ํ˜„๋ฌด์•”์ธต์„ ๋šซ๊ณ  ์œก์ง€ ์ง€ํ•˜๋กœ ํ˜๋Ÿฌ ๋“ค์–ด์˜จ ๋ฐ”๋‹ท๋ฌผ์ด๋‹ค. ์šฉ์•”ํ•ด์ˆ˜๋Š” ์ œ์ฃผ๋„์˜ ์„œ๋ถ€ ์ผ๋ถ€์ง€์—ญ๊ณผ ๋™๋ถ€์ง€์—ญ์„ ์ค‘์‹ฌ์œผ๋กœ ๋ฐœ๊ฒฌ๋˜๋ฉฐ ๊ณ ๋†๋„์˜ ๋ฏธ๋„ค๋ž„์„ ํ•จ์œ ํ•˜๊ณ  ์žˆ๋‹ค. ๋˜ํ•œ ์ผ๋ฐ˜ํ•ด์ˆ˜๋Š” ์ƒํ™œํ•˜์ˆ˜, ์‚ฐ์—…ํ์ˆ˜, ํ•ญ๋งŒ์˜ค์—ผ ๋“ฑ์˜ ๋ถˆ์•ˆ์ •ํ•œ ํ™˜๊ฒฝ์— ๋…ธ์ถœ๋˜์–ด ์‚ฐ์—…ํ™” ์†Œ์žฌ ๊ฐ€๊ณต์— ๋งŽ์€ ๋น„์šฉ์ด ์†Œ์š”๋˜๋Š” ๋ฐ˜๋ฉด, ์šฉ์•”ํ•ด์ˆ˜๋Š” ํ™”์‚ฐ์•”๋ฐ˜์ธต์— ์˜ํ•œ ์ž์—ฐ์ •ํ™”์™€ ์—ฌ๊ณผ๋ฅผ ๊ฑฐ์ณ ์ค‘๊ธˆ์† ํก์ฐฉ ๋ฐ ์œ ํ•ด๋ฌผ์งˆ์„ ์ฐจ๋‹จํ•˜๊ธฐ ๋•Œ๋ฌธ์— ์•ˆ์ „์„ฑ๊ณผ ์•ˆ์ •์„ฑ, ๊ฒฝ์ œ์„ฑ์„ ํ™•๋ณดํ•˜๊ณ  ์žˆ๊ณ , ๊นŠ์€ ๋ฐ”๋‹ค์—์„œ ์ทจ์ˆ˜ํ•˜๋Š” ํ•ด์–‘์‹ฌ์ธต์ˆ˜์— ๋น„ํ•ด์„œ ๋น„๊ตํ•  ์ˆ˜ ์—†์„ ์ •๋„๋กœ ์ทจ์ˆ˜๋น„์šฉ์ด ์ €๋ ดํ•˜๋‹ค.Lava seawater is seawater that penetrates the basalt layer of Jeju Island and flows underground. Lava seawater is found mainly in the western and eastern parts of Jeju Island and contains high concentrations of minerals. In addition, while general seawater is exposed to unstable environments such as domestic sewage, industrial wastewater, and port pollution, it takes a lot of money to process industrial materials, whereas lava seawater undergoes natural purification and filtration by volcanic bedrock to block heavy metal adsorption and harmful substances. Therefore, it secures safety, stability, and economic feasibility, and the cost of water intake is incomparably lower than that of deep sea water taken from the deep sea.

๋ณธ ์ถœ์›์˜ ๋ฐœ๋ช…์ž๋Š” ์ œ์ฃผ ์šฉ์•”ํ•ด์ˆ˜๋ฅผ ์ด์šฉํ•˜์—ฌ ์–‘์‹์„ ํ•˜๋Š” ๊ณผ์ •์—์„œ ์šฉ์•”ํ•ด์ˆ˜์™€ ํ•จ๊ป˜ ๋ถ€์ฐฉ์„ฑ ๊ทœ์กฐ๋ฅ˜๊ฐ€ ์ทจ์ˆ˜๋˜๋Š” ๊ฒƒ์„ ํ™•์ธํ•˜๊ณ , ์ด๋“ค ๋ถ€์ฐฉ์„ฑ ๊ทœ์กฐ๋ฅ˜๋ฅผ ์šฐ์ ์‹œ์ผœ ๋Œ€๋Ÿ‰ ๋ฐฐ์–‘ํ•˜๋Š” ๋ฐฉ๋ฒ•์„ ํ™•๋ฆฝํ•˜์˜€๋‹ค. ๋ถ€์ฐฉ์„ฑ ๊ทœ์กฐ๋ฅ˜๋Š” ์–‘์‹ ์‚ฐ์—…์˜ ์‚ฌ๋ฃŒ ๋Œ€์ฒด ์—๋„ˆ์ง€์›์œผ๋กœ์„œ ๋˜๋Š” ์˜ํ•™, ํ™˜๊ฒฝ, ์ƒ๋ช…์‚ฐ์—… ๋“ฑ ์—ฌ๋Ÿฌ ์‚ฐ์—…๋ถ„์•ผ์˜ ๊ธฐ์ดˆ์žฌ๋กœ์„œ ๊ฐ€์น˜๊ฐ€ ๋†’์€ ์ž์›์œผ๋กœ ํ™œ์šฉ๊ฐ€๋Šฅํ•˜๋‹ค.The inventor of the present application confirmed that adherent diatoms were taken together with lava seawater in the process of aquaculture using Jeju lava seawater, and established a method of mass-cultivating these adherent diatoms dominantly. Adherent diatoms can be used as a valuable resource as an alternative energy source for feed in the aquaculture industry or as a basic material in various industrial fields such as medicine, environment, and life industry.

ํ•œํŽธ, ์นด๋กœํ‹ฐ๋…ธ์ด๋“œ ์‹œ์žฅ์€ ํ•ฉ์„ฑ ์นด๋กœํ‹ฐ๋…ธ์ด๋“œ์™€ ์ฒœ์—ฐ๋ฌผ ์œ ๋ž˜ ์นด๋กœํ‹ฐ๋…ธ์ด๋“œ๋กœ ๋ถ„๋ฅ˜๋˜๋ฉฐ, ๊พธ์ค€ํ•œ ์„ฑ์žฅ์„ธ๋ฅผ ์ด๋ฃจ๊ณ  ์žˆ๋‹ค. ์ „ ์„ธ๊ณ„ ์นด๋กœํ‹ฐ๋…ธ์ด๋“œ ์‹œ์žฅ์€ 2014๋…„ 15์–ต ๋‹ฌ๋Ÿฌ๋ฅผ ๊ธฐ๋กํ•˜๊ณ , 2019๋…„์—๋Š” ์•ฝ 18์–ต ๋‹ฌ๋Ÿฌ๋กœ ์ฆ๊ฐ€ํ•  ๊ฒƒ์œผ๋กœ ์˜ˆ์ƒ๋œ๋‹ค. ํŠนํžˆ ๋ฃจํ…Œ์ธ, ์นธํƒ€์ž”ํ‹ด, ์•„์Šคํƒ€์ž”ํ‹ด ๋“ฑ์˜ ํฌ์‚ฐํ† ํ•„๊ณ„ ์นด๋กœํ‹ฐ๋…ธ์ด๋“œ์˜ ๊ฐ€์น˜๊ฐ€ ๋†’์•„์ง€๊ณ  ์žˆ์œผ๋ฉฐ, ์ฃผ๋กœ ์ฒœ์—ฐ์ƒ‰์†Œ, ํ•ญ์‚ฐํ™”์ œ, ๋น„ํƒ€๋ฏผA ์ „๊ตฌ์ฒด, ์–‘์‹ ์‚ฌ๋ฃŒ ์ฒจ๊ฐ€์ œ ๋“ฑ์œผ๋กœ ์‚ฌ์šฉ๋˜๊ณ  ์žˆ๋‹ค.On the other hand, the carotenoid market is classified into synthetic carotenoids and carotenoids derived from natural products, and is growing steadily. The global carotenoid market was valued at USD 1.5 billion in 2014 and is expected to increase to approximately USD 1.8 billion in 2019. In particular, the value of xanthophyll-based carotenoids such as lutein, canthaxanthin, and astaxanthin is increasing, and they are mainly used as natural pigments, antioxidants, vitamin A precursors, and aquaculture feed additives.

ํ›„์ฝ”์ž”ํ‹ด์€ ์ฃผ๋กœ ๋ฏธ์—ญ, ๋‹ค์‹œ๋งˆ, ๋ชจ์ž๋ฐ˜, ํ†ณ ๋“ฑ์˜ ๊ฐˆ์กฐ๋ฅ˜(brown algae)์— ์กด์žฌํ•˜๋Š” ์ผ์ข…์˜ ์นด๋กœํ‹ฐ๋…ธ์ด๋“œ๊ณ„(Carotenoid) ์ƒ‰์†Œ๋ฅผ ์˜๋ฏธํ•œ๋‹ค. ๊ฐˆ์กฐ๋ฅ˜๊ฐ€ ๊ฐˆ์ƒ‰์„ ๋‚˜ํƒ€๋‚ด๋Š” ๊ฒƒ์€ ํ›„์ฝ”์ž”ํ‹ด์ด๋ผ๋Š” ๊ณ ์œ ํ•œ ๊ด‘ํ•ฉ์„ฑ ์ƒ‰์†Œ๊ฐ€ ์—ฝ๋ก์†Œ์— ๋น„ํ•ด ์ƒ๋Œ€์ ์œผ๋กœ ๋งŽ๊ธฐ ๋•Œ๋ฌธ์ด๋‹ค. ๋น›์—๋„ˆ์ง€๋ฅผ ํฌ์ฐฉํ•ด ์•ฝ 80%๋ฅผ ์—ฝ๋ก์†Œ์— ์ „๋‹ฌํ•จ์œผ๋กœ์จ ๊ด‘ํ•ฉ์„ฑ์„ ๋ณด์กฐํ•œ๋‹ค. ํฌ์ฐฉ๋œ ๋น›์—๋„ˆ์ง€๋Š” ์ŠคํŽ™ํŠธ๋Ÿผ ์ƒ์˜ 450~540nm ํŒŒ์žฅ์˜ ๋น›์„ ํก์ˆ˜ํ•˜๋ฉฐ, 510~525nm ํŒŒ์žฅ์˜ ๋น›์„ ๊ฐ€์žฅ ๋งŽ์ด ํก์ˆ˜ํ•˜๋ฉฐ, ํ•ญ๋น„๋งŒ, ํ•ญ์—ผ์ฆ, ํ”ผ๋ถ€๋ณดํ˜ธ, ๋…ธํ™”์–ต์ œ ๋“ฑ ๋‹ค์–‘ํ•œ ํšจ๋Šฅ์ด ์žˆ๋Š” ๊ฒƒ์œผ๋กœ ์•Œ๋ ค์กŒ๋‹ค.Fucoxanthin refers to a kind of carotenoid pigment that is mainly present in brown algae such as seaweed, kelp, motherwort, and turmeric. Brown algae are brown because their unique photosynthetic pigment called fucoxanthin is relatively higher than that of chlorophyll. It assists photosynthesis by capturing light energy and delivering about 80% of it to chlorophyll. The captured light energy absorbs light with a wavelength of 450 to 540 nm on the spectrum, and absorbs the most light with a wavelength of 510 to 525 nm, and is known to have various effects such as anti-obesity, anti-inflammatory, skin protection, and anti-aging.

์šฐ๋ฆฌ๋‚˜๋ผ ์ œ์ฃผ ์šฉ์•”ํ•ด์ˆ˜์—์„œ ์ทจ์ˆ˜๋˜๋Š” ๋ถ€์ฐฉ์„ฑ ๊ทœ์กฐ๋ฅ˜๋กœ๋ถ€ํ„ฐ ํ›„์ฝ”์ž”ํ‹ด์„ ๋ถ„๋ฆฌ์ •์ œํ•˜๋Š” ์ตœ์ ์˜ ๋ฐฉ๋ฒ•์„ ์ œ๊ณตํ•œ๋‹ค.We provide an optimal method for separating and purifying fucoxanthin from adherent diatoms taken from lava seawater in Jeju, Korea.

์ƒ๊ธฐ์™€ ๊ฐ™์€ ๋ฌธ์ œ๋ฅผ ํ•ด๊ฒฐํ•˜๊ธฐ ์œ„ํ•ด ๋ณธ ๋ฐœ๋ช…์—์„œ๋Š” (S1) ๋Œ€๋Ÿ‰ ๋ฐฐ์–‘ํ•˜์—ฌ ์ˆ˜๊ฑฐ๋œ ๊ทœ์กฐ๋ฅ˜๋ฅผ 70% ์ฃผ์ •์— ๊ต๋ฐ˜ํ•˜๋Š” ๋‹จ๊ณ„; (S2) ๊ทœ์กฐํ† ๋กœ ์‚ฌ์ „์ฝ”ํŒ…(precoat)๋œ ์—ฌ๊ณผ๋ฒ ๋“œ(filter bed)์— loadingํ•˜์—ฌ ์—ฌ๊ณผํ•˜๋Š” ๋‹จ๊ณ„; (S3) ์—ฌ๊ณผ๋œ ์ถ”์ถœ๋ฌผ์„ ๋ถ„ํš ๋ฐ ๋†์ถ•ํ•˜๋Š” ๋‹จ๊ณ„; (S4) ๋†์ถ•๋œ ์ถ”์ถœ๋ฌผ์—์„œ ํ›„์ฝ”์ž”ํ‹ด์„ ๋ถ„๋ฆฌ์ •์ œํ•˜๋Š” ๋‹จ๊ณ„; ๋ฐ (S5) ๋ถ„๋ฆฌ์ •์ œ๋œ ํ›„์ฝ”์ž”ํ‹ด์„ ์•”์‹ค์— ๋ณด๊ด€ํ•˜๋Š” ๋‹จ๊ณ„๋กœ ์ด๋ฃจ์–ด์ง€๋Š” ๊ทœ์กฐ๋ฅ˜ ์œ ๋ž˜ ํ›„์ฝ”์ž”ํ‹ด์˜ ๋ถ„๋ฆฌ์ •์ œ๋ฐฉ๋ฒ•์„ ์ œ๊ณตํ•œ๋‹ค.In the present invention in order to solve the above problems, (S1) agitating the diatoms collected by mass culture in 70% alcohol; (S2) loading and filtering on a filter bed pre-coated with diatomaceous earth; (S3) fractionating and concentrating the filtered extract; (S4) separating and purifying fucoxanthin from the concentrated extract; And (S5) provides a separation and purification method of diatom-derived fucoxanthin comprising the step of storing the separated and purified fucoxanthin in a dark room.

๋ณธ ๋ฐœ๋ช…์— ์žˆ์–ด์„œ, ๊ทœ์กฐ๋ฅ˜๋Š” ์ œ์ฃผ ์šฉ์•” ํ•ด์ˆ˜์™€ ํ•จ๊ป˜ ์ทจ์ˆ˜๋˜๋Š” ๋ถ€์ฐฉ์„ฑ ๊ทœ์กฐ๋ฅ˜์ผ ์ˆ˜ ์žˆ๋‹ค.In the present invention, the diatoms may be adherent diatoms that are taken together with Jeju lava seawater.

๋ณธ ๋ฐœ๋ช…์— ์žˆ์–ด์„œ, ๋ถ€์ฐฉ์„ฑ ๊ทœ์กฐ๋ฅ˜๋Š” Melosira nummuloides, Achnanthes brevipes var. intermedia, Achnanthes sancti-pauli, Achnanthes brevipes ๋˜๋Š” Melosira octogona ๋กœ ์ด๋ฃจ์–ด์ง„ ๊ตฐ ์ค‘ ์„ ํƒ๋œ ํ•œ ์ข… ์ด์ƒ์ผ ์ˆ˜ ์žˆ๋‹ค. In the present invention, the adherent diatoms are Melosira nummuloides, Achnanthes brevipes var. It may be at least one species selected from the group consisting of intermedia, Achnanthes sancti-pauli, Achnanthes brevipes, or Melosira octogona.

๋ณธ ๋ฐœ๋ช…์— ์žˆ์–ด์„œ, ์ƒ๊ธฐ ๊ทœ์กฐ๋ฅ˜๋Š” ๋ฐ”๋‹ฅ๊ทœ์กฐ ๋ฐฐ์–‘๋ฌผ์—์„œ ์ˆ˜๊ฑฐ๋˜๋Š” ๊ทœ์กฐ๋ฅ˜์ผ ์ˆ˜ ์žˆ๋‹ค.In the present invention, the diatoms may be diatoms collected from a bottom diatom culture.

๋ณธ ๋ฐœ๋ช…์— ์žˆ์–ด์„œ, (S1)๋‹จ๊ณ„๋Š” ์›๋ฌผ ๋Œ€๋น„ 7๋ฐฐ(v/v)์˜ ์ฃผ์ •๋Ÿ‰์œผ๋กœ 1์ผ๊ฐ„ ์ฒ˜๋ฆฌํ•˜๋Š” ๊ฒƒ์„ ํŠน์ง•์œผ๋กœ ํ•  ์ˆ˜ ์žˆ๋‹ค.In the present invention, step (S1) may be characterized in that it is treated with an alcohol amount of 7 times (v/v) compared to the raw material for 1 day.

๋ณธ ๋ฐœ๋ช…์— ์žˆ์–ด์„œ, (S1)๋‹จ๊ณ„์—์„œ 25๋ถ„๊ฐ„ plasma๋ฅผ ์ฒ˜๋ฆฌํ•˜๋Š” ๋‹จ๊ณ„๋ฅผ ๋” ํฌํ•จํ•  ์ˆ˜ ์žˆ๋‹ค.In the present invention, it may further include the step of treating plasma for 25 minutes in step (S1).

๋ณธ ๋ฐœ๋ช…์— ์žˆ์–ด์„œ, (S4) ๋†์ถ•๋œ ์ถ”์ถœ๋ฌผ์—์„œ ํ›„์ฝ”์ž”ํ‹ด์„ ๋ถ„๋ฆฌ์ •์ œํ•˜๋Š” ๋‹จ๊ณ„๋Š” ์‹ค๋ฆฌ์นด ๊ฒ” ์ปฌ๋Ÿผ ํฌ๋กœ๋งˆํ† ๊ทธ๋ž˜ํ”ผ(silica gel column chromatography)์— ์˜ํ•˜์—ฌ ์ด๋ฃจ์–ด์ง€๋Š” ๊ฒƒ์„ ํŠน์ง•์œผ๋กœ ํ•  ์ˆ˜ ์žˆ๋‹ค.In the present invention, (S4) the step of separating and purifying fucoxanthin from the concentrated extract may be characterized in that it is performed by silica gel column chromatography.

๋ณธ ๋ฐœ๋ช…์— ์žˆ์–ด์„œ, ์ƒ๊ธฐ ์‹ค๋ฆฌ์นด ๊ฒ” ์ปฌ๋Ÿผ ํฌ๋กœ๋งˆํ† ๊ทธ๋ž˜ํ”ผ์— ์‚ฌ์šฉ๋˜๋Š” ์šฉ์ถœ์šฉ๋งค๋Š” N-hexane๊ณผ Acetone์˜ ๋น„์œจ์ด 7 : 3 ์ธ ๊ฒƒ์„ ํŠน์ง•์œผ๋กœ ํ•  ์ˆ˜ ์žˆ๋‹ค.In the present invention, the elution solvent used for the silica gel column chromatography may be characterized in that the ratio of N-hexane to acetone is 7:3.

๋ณธ ๋ฐœ๋ช…์€ ์šฐ๋ฆฌ๋‚˜๋ผ ์ œ์ฃผ ์šฉ์•”ํ•ด์ˆ˜์—์„œ ์ทจ์ˆ˜๋˜๋Š” ๋ถ€์ฐฉ์„ฑ ๊ทœ์กฐ๋ฅ˜๋กœ๋ถ€ํ„ฐ ํ›„์ฝ”์ž”ํ‹ด์„ ๋ถ„๋ฆฌ์ •์ œํ•˜๋Š” ์ตœ์ ์˜ ๋ฐฉ๋ฒ•์„ ์ œ๊ณตํ•˜๋Š” ๋ฐ”, ๋Œ€๋Ÿ‰์œผ๋กœ ๋ฐฐ์–‘๋œ ๋ถ€์ฐฉ์„ฑ ๊ทœ์กฐ๋ฅ˜๋กœ๋ถ€ํ„ฐ ๋ถ„๋ฆฌ์ •์ œ๋œ ๊ณ ์ˆœ๋„์˜ ํ›„์ฝ”์ž”ํ‹ด์„ ์ด์šฉํ•˜์—ฌ ์˜๋ฃŒ๋ถ„์•ผ, ๋ฏธ์šฉ๋ถ„์•ผ ๋“ฑ ๋‹ค์–‘ํ•œ ์‚ฐ์—…๋ถ„์•ผ์—์„œ ํ™œ์šฉ์ด ๊ฐ€๋Šฅํ•˜๋‹ค.The present invention provides an optimal method for separating and purifying fucoxanthin from adherent diatoms taken from lava seawater in Jeju, Korea. Using high-purity fucoxanthin separated and purified from adherent diatoms cultured in large quantities, medical and cosmetic It can be used in various industrial fields such as fields.

๋„ 1์€ ๊ทœ์กฐ๋ฃŒ ์›๋ฌผ์„ ์ฃผ์ •์— ๊ต๋ฐ˜ ํ›„ ๊ทœ์กฐํ† ๋กœ ์‚ฌ์ „์ฝ”ํŒ…(precoat)๋œ ์—ฌ๊ณผ๋ฒ ๋“œ(filter bed)์— loadingํ•˜์—ฌ ์—ฌ๊ณผํ•˜๊ณ , ์‹ค๋ฆฌ์นด ๊ฒ” ์ปฌ๋Ÿผ ํฌ๋กœ๋งˆํ† ๊ทธ๋ž˜ํ”ผ์— ์˜ํ•˜์—ฌ ๋ถ„๋ฆฌ์ •์ œ๋œ ํ›„์ฝ”์ž”ํ‹ด์„ ๋ฉ”ํƒ„์˜ฌ์— ๋…น์ธ ํ‘œ์ค€์šฉ์•ก 1์— ๋Œ€ํ•œ HPLC ๋ถ„์„์„ ๋‚˜ํƒ€๋‚ธ ๊ฒƒ์ด๋‹ค.1 is a standard solution 1 in which the raw material of diatomaceous material is stirred in alcohol, loaded on a filter bed pre-coated with diatomaceous earth and filtered, and fucoxanthin purified by silica gel column chromatography is dissolved in methanol. HPLC analysis for

๋„ 2๋Š” ๊ทœ์กฐ๋ฃŒ ์›๋ฌผ์„ ์ฃผ์ •์— ๊ต๋ฐ˜ ํ›„ ๊ทœ์กฐํ† ๋กœ ์‚ฌ์ „์ฝ”ํŒ…(precoat)๋œ ์—ฌ๊ณผ๋ฒ ๋“œ(filter bed)์— loadingํ•˜์—ฌ ์—ฌ๊ณผํ•˜๊ณ , ์ดํ‹€๋™์•ˆ -20โ„ƒ์—์„œ ๋ณด๊ด€ํ•˜์—ฌ ์žฌ๊ฒฐ์ •์„ ์‹ค์‹œํ•œ ํ‘œ์ค€์šฉ์•ก 2์˜ ๋ชจ์•ก์— ๋Œ€ํ•œ HPLC ๋ถ„์„์„ ๋‚˜ํƒ€๋‚ธ ๊ฒƒ์ด๋‹ค.Figure 2 is HPLC for the mother liquid of standard solution 2, in which the raw material of diatomaceous material was stirred in alcohol, loaded on a filter bed pre-coated with diatomaceous earth, filtered, and stored at -20ยฐC for two days for recrystallization. analysis is shown.

๋„ 3์€ ๊ทœ์กฐ๋ฃŒ ์›๋ฌผ์„ ์ฃผ์ •์— ๊ต๋ฐ˜ ํ›„ ๊ทœ์กฐํ† ๋กœ ์‚ฌ์ „์ฝ”ํŒ…(precoat)๋œ ์—ฌ๊ณผ๋ฒ ๋“œ(filter bed)์— loadingํ•˜์—ฌ ์—ฌ๊ณผํ•˜๊ณ , ์ดํ‹€๋™์•ˆ -20โ„ƒ์—์„œ ๋ณด๊ด€ํ•˜์—ฌ ์žฌ๊ฒฐ์ •์„ ์‹ค์‹œํ•œ ํ‘œ์ค€์šฉ์•ก 2์˜ ๊ฒฐ์ •์— ๋Œ€ํ•œ HPLC ๋ถ„์„์„ ๋‚˜ํƒ€๋‚ธ ๊ฒƒ์ด๋‹ค.Figure 3 is HPLC for the crystallization of standard solution 2, in which the raw material of diatomaceous material is stirred in alcohol, loaded on a filter bed pre-coated with diatomaceous earth, filtered, and stored at -20ยฐC for two days for recrystallization. analysis is shown.

๋„ 4๋Š” ์ƒ๊ธฐ ํ‘œ์ค€์šฉ์•ก 1๊ณผ ๋™์ผํ•˜๊ฒŒ ์ œ์กฐํ•˜๋˜ ํƒˆ์—ผ๋ฐ˜์‘์„ ์ง„ํ–‰ํ•˜์ง€ ์•„๋‹ˆํ•œ ํ‘œ์ค€์šฉ์•ก 3์— ๋Œ€ํ•œ HPLC ๋ถ„์„์„ ๋‚˜ํƒ€๋‚ธ ๊ฒƒ์ด๋‹ค.Figure 4 shows the HPLC analysis of the standard solution 3 prepared in the same manner as the standard solution 1, but without the desalting reaction.

๋„ 5๋Š” ์ƒ๊ธฐ ํ‘œ์ค€์šฉ์•ก 1๊ณผ ๋™์ผํ•˜๊ฒŒ ์ œ์กฐํ•˜๋˜ ํƒˆ์—ผ๋ฐ˜์‘์„ ์ง„ํ–‰ํ•œ ํ‘œ์ค€์šฉ์•ก 3์— ๋Œ€ํ•œ HPLC ๋ถ„์„์„ ๋‚˜ํƒ€๋‚ธ ๊ฒƒ์ด๋‹ค.Figure 5 shows the HPLC analysis of the standard solution 3 prepared in the same manner as the standard solution 1, but subjected to a desalting reaction.

๋„ 6์€ ์ƒ๊ธฐ ํ‘œ์ค€์šฉ์•ก 1๊ณผ ๋™์ผํ•˜๊ฒŒ ์ œ์กฐํ•˜๋˜ ํ–‡๋น›์— ๋…ธ์ถœํ•œ ํ‘œ์ค€์šฉ์•ก 4์— ๋Œ€ํ•œ HPLC ๋ถ„์„์„ ๋‚˜ํƒ€๋‚ธ ๊ฒƒ์ด๋‹ค.6 shows the HPLC analysis of the standard solution 4 prepared in the same manner as the standard solution 1, but exposed to sunlight.

๋„ 7์€ ํ‘œ 1์˜ Sample No 4์— ๋Œ€ํ•œ HPLC ์ •๋Ÿ‰๋ถ„์„์„ ๋‚˜ํƒ€๋‚ธ ๊ฒƒ์ด๋‹ค.7 shows the HPLC quantitative analysis of Sample No 4 of Table 1.

๋„ 8์€ ํ‘œ 1์˜ Sample No 5์— ๋Œ€ํ•œ HPLC ์ •๋Ÿ‰๋ถ„์„์„ ๋‚˜ํƒ€๋‚ธ ๊ฒƒ์ด๋‹ค.8 shows the HPLC quantitative analysis of Sample No 5 of Table 1.

๋„ 9๋Š” ํ‘œ 1์˜ Sample No 6์— ๋Œ€ํ•œ HPLC ์ •๋Ÿ‰๋ถ„์„์„ ๋‚˜ํƒ€๋‚ธ ๊ฒƒ์ด๋‹ค.9 shows the HPLC quantitative analysis of Sample No 6 of Table 1.

๋„ 10์€ ํ›„์ฝ”์ž”ํ‹ด ๋ถ„๋ฆฌ์ •์ œ ๊ณต์ •์˜ ๊ฐœ๋žต๋„๋ฅผ ๋‚˜ํƒ€๋‚ธ ๊ฒƒ์ด๋‹ค.Figure 10 shows a schematic diagram of the fucoxanthin separation and purification process.

๋„ 11์€ ์‹ค๋ฆฌ์นด ๊ฒ” ์ปฌ๋Ÿผ ํฌ๋กœ๋งˆํ† ๊ทธ๋ž˜ํ”ผ(silica gel column chromatography)์— ์˜ํ•œ ํ›„์ฝ”์ž”ํ‹ด ๋ถ„๋ฆฌ์ •์ œ ๊ณต์ •์„ ๋‚˜ํƒ€๋‚ธ ๊ฒƒ์ด๋‹ค.Figure 11 shows the fucoxanthin separation and purification process by silica gel column chromatography (silica gel column chromatography).

๋„ 12๋Š” ํ›„์ฝ”์ž”ํ‹ด์„ ํฌํ•จํ•˜๋Š” ๋ถ„ํš๋ฌผ์˜ TLC(Thin Layer Chromatography) ๊ฒฐ๊ณผ๋ฅผ ๋‚˜ํƒ€๋‚ธ ๊ฒƒ์ด๋‹ค.Figure 12 shows the results of TLC (Thin Layer Chromatography) of the fraction containing fucoxanthin.

๋„ 13์€ ํ›„์ฝ”์ž”ํ‹ด์˜ ๋†์ถ•๊ณผ์ •์„ ๋‚˜ํƒ€๋‚ธ ๊ฒƒ์ด๋‹ค.13 shows the concentration process of fucoxanthin.

๋„ 14๋Š” ํ‘œ์ค€ ํ›„์ฝ”์ž”ํ‹ด(Sigma Aldrich์—์„œ ๊ตฌ์ž…)์„ ์ด์šฉํ•œ ํ‘œ์ค€๊ฒ€๋Ÿ‰์„  ์ž‘์„ฑ์„ ๋‚˜ํƒ€๋‚ธ ๊ฒƒ์ด๋‹ค.14 shows the creation of a standard calibration curve using standard fucoxanthin (purchased from Sigma Aldrich).

๋„ 15๋Š” ๊ทœ์กฐ๋ถ„๋ง์˜ 70% ์ฃผ์ • ์ถ”์ถœ๋ฌผ๋กœ๋ถ€ํ„ฐ ๋ถ„ํš/๋†์ถ•๊ณผ์ •์„ ํ†ตํ•˜์—ฌ ์ตœ์ข…์ ์œผ๋กœ ์–ป์–ด์ง„ ์ˆœ๋„ 60% ํ›„์ฝ”์ž”ํ‹ด์˜ HPLC ์ •๋Ÿ‰๋ถ„์„์„ ๋‚˜ํƒ€๋‚ธ ๊ฒƒ์ด๋‹ค.15 shows HPLC quantitative analysis of 60% pure fucoxanthin finally obtained through fractionation/concentration process from 70% alcohol extract of diatom powder.

๋„ 16์€ ๊ทœ์กฐํ†  ์‚ฌ์ „์ฝ”ํŒ…(precoat) ์—ฌ๊ณผ ๋ฐ ์žฌ๊ฒฐ์ •ํ™” ๊ณผ์ •์„ ๋‚˜ํƒ€๋‚ธ ๊ฒƒ์ด๋‹ค.16 shows the diatomaceous earth precoat filtration and recrystallization process.

๋„ 17์€ ์—ฌ๊ณผ๊ณผ์ • ๋ฐ ์žฌ๊ฒฐ์ •์˜ ํ˜„๋ฏธ๊ฒฝ ๊ด€์ฐฐ์‚ฌ์ง„(ร—400)์„ ๋‚˜ํƒ€๋‚ธ ๊ฒƒ์ด๋‹ค.17 shows a microscopic observation photograph (ร—400) of the filtration process and recrystallization.

๋„ 18์€ ์žฌ๊ฒฐ์ •์„ ์‹ค์‹œํ•œ ํ›„์ฝ”์ž”ํ‹ด์˜ HPLC ์ •๋Ÿ‰๋ถ„์„์„ ๋‚˜ํƒ€๋‚ธ ๊ฒƒ์ด๋‹ค.18 shows the HPLC quantitative analysis of fucoxanthin subjected to recrystallization.

๋„ 19๋Š” ํ‘œ 3์˜ Sample No 1์˜ HPLC ์ •๋Ÿ‰๋ถ„์„์„ ๋‚˜ํƒ€๋‚ธ ๊ฒƒ์ด๋‹ค.Figure 19 shows the HPLC quantitative analysis of Sample No 1 of Table 3.

๋„ 20์€ ํ‘œ 3์˜ Sample No 3์˜ HPLC ์ •๋Ÿ‰๋ถ„์„์„ ๋‚˜ํƒ€๋‚ธ ๊ฒƒ์ด๋‹ค.20 shows the HPLC quantitative analysis of Sample No 3 of Table 3.

๋„ 21์€ ํ‘œ 3์˜ Sample No 15์˜ HPLC ์ •๋Ÿ‰๋ถ„์„์„ ๋‚˜ํƒ€๋‚ธ ๊ฒƒ์ด๋‹ค.Figure 21 shows the HPLC quantitative analysis of Sample No 15 of Table 3.

๋„ 22๋Š” ํ‘œ 3์˜ Sample No 16์˜ HPLC ์ •๋Ÿ‰๋ถ„์„์„ ๋‚˜ํƒ€๋‚ธ ๊ฒƒ์ด๋‹ค.Figure 22 shows the HPLC quantitative analysis of Sample No 16 of Table 3.

๋„ 23์€ ํ›„์ฝ”์ž”ํ‹ด์˜ ๋ถ„๋ง์ œํ˜•์„ ๋‚˜ํƒ€๋‚ธ ๊ฒƒ์ด๋‹ค.23 shows a powder formulation of fucoxanthin.

๋„ 24๋Š” ํ‘œ 3์˜ Sample No 8์˜ HPLC ์ •๋Ÿ‰๋ถ„์„์„ ๋‚˜ํƒ€๋‚ธ ๊ฒƒ์ด๋‹ค.Figure 24 shows the HPLC quantitative analysis of Sample No 8 of Table 3.

๋„ 25๋Š” ํ‘œ 3์˜ Sample No 9์˜ HPLC ์ •๋Ÿ‰๋ถ„์„์„ ๋‚˜ํƒ€๋‚ธ ๊ฒƒ์ด๋‹ค.25 shows the HPLC quantitative analysis of Sample No 9 of Table 3.

๋„ 26์€ ํ‘œ 3์˜ Sample No 10์˜ HPLC ์ •๋Ÿ‰๋ถ„์„์„ ๋‚˜ํƒ€๋‚ธ ๊ฒƒ์ด๋‹ค.26 shows the HPLC quantitative analysis of Sample No 10 of Table 3.

๋„ 27์€ ํ‘œ 3์˜ Sample No 11์˜ HPLC ์ •๋Ÿ‰๋ถ„์„์„ ๋‚˜ํƒ€๋‚ธ ๊ฒƒ์ด๋‹ค.27 shows the HPLC quantitative analysis of Sample No 11 of Table 3.

๋„ 28 ๋‚ด์ง€ ๋„47์€ ํ‘œ 6์˜ sample 1 ๋‚ด์ง€ 20์— ๋Œ€ํ•œ HPLC ์ •๋Ÿ‰๋ถ„์„์„ ๋‚˜ํƒ€๋‚ธ ๊ฒƒ์ด๋‹ค.28 to 47 show HPLC quantitative analysis of samples 1 to 20 of Table 6.

๋ณธ ๋ฐœ๋ช…์— ์˜ํ•œ ์ผ ์‹ค์‹œ์˜ˆ๋กœ์„œ, (S1) ๋Œ€๋Ÿ‰ ๋ฐฐ์–‘ํ•˜์—ฌ ์ˆ˜๊ฑฐ๋œ ๊ทœ์กฐ๋ฅ˜๋ฅผ 70% ์ฃผ์ •์— ๊ต๋ฐ˜ํ•˜๋Š” ๋‹จ๊ณ„; (S2) ๊ทœ์กฐํ† ๋กœ ์‚ฌ์ „์ฝ”ํŒ…(precoat)๋œ ์—ฌ๊ณผ๋ฒ ๋“œ(filter bed)์— loadingํ•˜์—ฌ ์—ฌ๊ณผํ•˜๋Š” ๋‹จ๊ณ„; (S3) ์—ฌ๊ณผ๋œ ์ถ”์ถœ๋ฌผ์„ ๋ถ„ํš ๋ฐ ๋†์ถ•ํ•˜๋Š” ๋‹จ๊ณ„; (S4) ๋†์ถ•๋œ ์ถ”์ถœ๋ฌผ์—์„œ ํ›„์ฝ”์ž”ํ‹ด์„ ๋ถ„๋ฆฌ์ •์ œํ•˜๋Š” ๋‹จ๊ณ„; ๋ฐ (S5) ๋ถ„๋ฆฌ์ •์ œ๋œ ํ›„์ฝ”์ž”ํ‹ด์„ ์•”์‹ค์— ๋ณด๊ด€ํ•˜๋Š” ๋‹จ๊ณ„๋กœ ์ด๋ฃจ์–ด์ง€๋Š” ๊ทœ์กฐ๋ฅ˜ ์œ ๋ž˜ ํ›„์ฝ”์ž”ํ‹ด์˜ ๋ถ„๋ฆฌ์ •์ œ๋ฐฉ๋ฒ•์„ ์ œ๊ณตํ•œ๋‹ค.As an embodiment of the present invention, (S1) agitating the diatoms collected by mass culture in 70% alcohol; (S2) loading and filtering on a filter bed pre-coated with diatomaceous earth; (S3) fractionating and concentrating the filtered extract; (S4) separating and purifying fucoxanthin from the concentrated extract; And (S5) provides a separation and purification method of diatom-derived fucoxanthin comprising the step of storing the separated and purified fucoxanthin in a dark room.

๋ณธ ๋ฐœ๋ช…์— ์˜ํ•œ ๋‹ค๋ฅธ ์‹ค์‹œ์˜ˆ์—์„œ, ๊ทœ์กฐ๋ฅ˜๋Š” ์ œ์ฃผ ์šฉ์•” ํ•ด์ˆ˜์™€ ํ•จ๊ป˜ ์ทจ์ˆ˜๋˜๋Š” ๋ถ€์ฐฉ์„ฑ ๊ทœ์กฐ๋ฅ˜์ผ ์ˆ˜ ์žˆ๋‹ค.In another embodiment according to the present invention, the diatoms may be adherent diatoms that are taken together with Jeju lava seawater.

๋ณธ ๋ฐœ๋ช…์— ์˜ํ•œ ๋˜ ๋‹ค๋ฅธ ์‹ค์‹œ์˜ˆ์—์„œ, ๋ถ€์ฐฉ์„ฑ ๊ทœ์กฐ๋ฅ˜๋Š” Melosira nummuloides, Achnanthes brevipes var. intermedia, Achnanthes sancti-pauli, Achnanthes brevipes ๋˜๋Š” Melosira octogona ๋กœ ์ด๋ฃจ์–ด์ง„ ๊ตฐ ์ค‘ ์„ ํƒ๋œ ํ•œ ์ข… ์ด์ƒ์ผ ์ˆ˜ ์žˆ๋‹ค. In another embodiment according to the present invention, the adherent diatom is Melosira nummuloides, Achnanthes brevipes var. It may be at least one species selected from the group consisting of intermedia, Achnanthes sancti-pauli, Achnanthes brevipes, or Melosira octogona.

๋ณธ ๋ฐœ๋ช…์— ์˜ํ•œ ๋˜ ๋‹ค๋ฅธ ์‹ค์‹œ์˜ˆ์—์„œ, ์ƒ๊ธฐ ๊ทœ์กฐ๋ฅ˜๋Š” ๋ฐ”๋‹ฅ๊ทœ์กฐ ๋ฐฐ์–‘๋ฌผ์—์„œ ์ˆ˜๊ฑฐ๋˜๋Š” ๊ทœ์กฐ๋ฅ˜์ผ ์ˆ˜ ์žˆ๋‹ค.In another embodiment according to the present invention, the diatoms may be diatoms collected from a bottom diatom culture.

๋ณธ ๋ฐœ๋ช…์— ์˜ํ•œ ๋˜ ๋‹ค๋ฅธ ์‹ค์‹œ์˜ˆ์—์„œ, (S1)๋‹จ๊ณ„๋Š” ์›๋ฌผ ๋Œ€๋น„ 7๋ฐฐ(v/v)์˜ ์ฃผ์ •๋Ÿ‰์œผ๋กœ 1์ผ๊ฐ„ ์ฒ˜๋ฆฌํ•˜๋Š” ๊ฒƒ์„ ํŠน์ง•์œผ๋กœ ํ•  ์ˆ˜ ์žˆ๋‹ค.In another embodiment according to the present invention, step (S1) may be characterized in that it is treated with an alcohol amount of 7 times (v/v) compared to the raw material for 1 day.

๋ณธ ๋ฐœ๋ช…์— ์˜ํ•œ ๋˜ ๋‹ค๋ฅธ ์‹ค์‹œ์˜ˆ์—์„œ, (S1)๋‹จ๊ณ„์—์„œ 25๋ถ„๊ฐ„ plasma๋ฅผ ์ฒ˜๋ฆฌํ•˜๋Š” ๋‹จ๊ณ„๋ฅผ ๋” ํฌํ•จํ•  ์ˆ˜ ์žˆ๋‹ค.In another embodiment according to the present invention, it may further include the step of treating plasma for 25 minutes in step (S1).

๋ณธ ๋ฐœ๋ช…์— ์˜ํ•œ ๋˜ ๋‹ค๋ฅธ ์‹ค์‹œ์˜ˆ์—์„œ, (S4) ๋†์ถ•๋œ ์ถ”์ถœ๋ฌผ์—์„œ ํ›„์ฝ”์ž”ํ‹ด์„ ๋ถ„๋ฆฌ์ •์ œํ•˜๋Š” ๋‹จ๊ณ„๋Š” ์‹ค๋ฆฌ์นด ๊ฒ” ์ปฌ๋Ÿผ ํฌ๋กœ๋งˆํ† ๊ทธ๋ž˜ํ”ผ(silica gel column chromatography)์— ์˜ํ•˜์—ฌ ์ด๋ฃจ์–ด์ง€๋Š” ๊ฒƒ์„ ํŠน์ง•์œผ๋กœ ํ•  ์ˆ˜ ์žˆ๋‹ค.In another embodiment according to the present invention, (S4) the step of separating and purifying fucoxanthin from the concentrated extract may be characterized in that it is performed by silica gel column chromatography.

๋ณธ ๋ฐœ๋ช…์— ์˜ํ•œ ๋˜ ๋‹ค๋ฅธ ์‹ค์‹œ์˜ˆ์—์„œ, ์ƒ๊ธฐ ์‹ค๋ฆฌ์นด ๊ฒ” ์ปฌ๋Ÿผ ํฌ๋กœ๋งˆํ† ๊ทธ๋ž˜ํ”ผ์— ์‚ฌ์šฉ๋˜๋Š” ์šฉ์ถœ์šฉ๋งค๋Š” N-hexane๊ณผ Acetone์˜ ๋น„์œจ์ด 7 : 3 ์ธ ๊ฒƒ์„ ํŠน์ง•์œผ๋กœ ํ•  ์ˆ˜ ์žˆ๋‹ค.In another embodiment of the present invention, the elution solvent used for the silica gel column chromatography may be characterized in that the ratio of N-hexane to acetone is 7:3.

์ดํ•˜, ๊ตฌ์ฒด์ ์ธ ์‹ค์‹œ์˜ˆ๋ฅผ ํ†ตํ•˜์—ฌ ๋ณธ ๋ฐœ๋ช…์„ ๋ณด๋‹ค ์ƒ์„ธํžˆ ์„ค๋ช…ํ•˜๊ณ ์ž ํ•œ๋‹ค. ์ด๋“ค ์‹ค์‹œ์˜ˆ๋Š” ์˜ค๋กœ์ง€ ๋ณธ ๋ฐœ๋ช…์„ ๋ณด๋‹ค ๊ตฌ์ฒด์ ์œผ๋กœ ์„ค๋ช…ํ•˜๊ธฐ ์œ„ํ•œ ๊ฒƒ์œผ๋กœ, ๋ณธ ๋ฐœ๋ช…์˜ ์š”์ง€์— ๋”ฐ๋ผ ๋ณธ ๋ฐœ๋ช…์˜ ๋ฒ”์œ„๊ฐ€ ์ด๋“ค ์‹ค์‹œ์˜ˆ์— ์˜ํ•ด ์ œํ•œ๋˜์ง€ ์•Š๋Š”๋‹ค๋Š” ๊ฒƒ์€ ๋‹น์—…๊ณ„์—์„œ ํ†ต์ƒ์˜ ์ง€์‹์„ ๊ฐ€์ง„ ์ž์—๊ฒŒ ์žˆ์–ด์„œ ์ž๋ช…ํ•  ๊ฒƒ์ด๋‹ค.Hereinafter, the present invention will be described in more detail through specific examples. These examples are only for illustrating the present invention in more detail, and it will be apparent to those of ordinary skill in the art that the scope of the present invention is not limited by these examples according to the gist of the present invention. .

์‹ค์‹œ์˜ˆ 1. ํ›„์ฝ”์ž”ํ‹ด ๋ถ„๋ฆฌ์ •์ œ๋ฐฉ๋ฒ•์˜ ์ตœ์ ํ™”Example 1. Optimization of fucoxanthin separation and purification method

๋ถ„๋ฆฌ์ •์ œ๋ฐฉ๋ฒ•์— ๋”ฐ๋ฅธ ํ›„์ฝ”์ž”ํ‹ด์˜ ํ•จ๋Ÿ‰๋ณ€ํ™”๋ฅผ ์ธก์ •ํ•˜์—ฌ ๋ถ„๋ฆฌ์ •์ œ๋ฐฉ๋ฒ•์„ ์ตœ์ ํ™”ํ•˜์˜€๋‹ค. ์ด๋ฅผ ์œ„ํ•˜์—ฌ ๋จผ์ € wet ์ƒํƒœ์˜ ๊ทœ์กฐ๋ฅ˜๋ฅผ 50g์”ฉ ๋‹ด์•„ ์ง„๊ณต๊ฑด์กฐ๊ธฐ์—์„œ 48์‹œ๊ฐ„ ๊ฑด์กฐ๋ฅผ ํ•˜์˜€๊ณ , ์ดํ›„ ๋‹ค์–‘ํ•œ ๊ณต์ •์— ์˜ํ•œ ํ›„์ฝ”์ž”ํ‹ด์˜ ํ•จ๋Ÿ‰๋ณ€ํ™”๋ฅผ HPLC๋ฅผ ์ด์šฉํ•˜์—ฌ ์ธก์ •ํ•˜์˜€๋‹ค.The separation and purification method was optimized by measuring the change in the content of fucoxanthin according to the separation and purification method. To this end, 50 g of diatoms in wet state were first put and dried in a vacuum dryer for 48 hours, and thereafter, the change in the content of fucoxanthin by various processes was measured using HPLC.

๋จผ์ €, ํ‘œ์ค€์šฉ์•ก 1์€ ๊ทœ์กฐ๋ฅ˜ ์›๋ฌผ์„ 70% ์ฃผ์ •์— 2์‹œ๊ฐ„ ๋™์•ˆ ๊ต๋ฐ˜ ํ›„ ๊ทœ์กฐํ† ๋กœ ์‚ฌ์ „์ฝ”ํŒ…(precoat)๋œ ์—ฌ๊ณผ๋ฒ ๋“œ(filter bed)์— loadingํ•˜์—ฌ ์—ฌ๊ณผ ํ›„ ๊ฐ์••๋†์ถ•์„ ์‹ค์‹œํ•˜์˜€๋‹ค. ์ด์— ๋”ฐ๋ฅธ sample 1.2g์„ ์ „์ž์ €์šธ๋กœ ์นญ๋Ÿ‰ํ•˜์—ฌ ์‹ค๋ฆฌ์นด ๊ฒ” ์ปฌ๋Ÿผ ํฌ๋กœ๋งˆํ† ๊ทธ๋ž˜ํ”ผ(silica gel column chromatography, ฮฆ 3.5 cm x 15 cm)๋ฅผ ์‹ค์‹œํ•˜์˜€๊ณ , ์šฉ์ถœ์šฉ๋งค๋กœ๋Š” N-Hexane : Acetone = 70 : 30 ์œผ๋กœ ํ˜๋ ค์ฃผ์—ˆ๋‹ค. ๋ถ„๋ฆฌ์ •์ œ๋œ ํ›„์ฝ”์ž”ํ‹ด์„ methanol์— ๋…น์—ฌ์„œ ๋†๋„ 0.1% ์ธ ํ‘œ์ค€์šฉ์•ก 1์„ ์ œ์กฐํ•˜์˜€๋‹ค. ์ด ํ›„, ํ‘œ์ค€์šฉ์•ก 1์„ ํˆฌ๋ช…์šฉ๊ธฐ์— ๋ถ„์ฃผํ•˜๊ณ  ํ›„์ฝ”์ž”ํ‹ด ํ•จ๋Ÿ‰์„ HPLC ๋ฐฉ๋ฒ•์œผ๋กœ ์ธก์ •ํ•˜์˜€๋‹ค. ์ƒ‰๋ณ€ํ™”๋Š” ๋‚˜ํƒ€๋‚˜์ง€ ์•Š์•˜์œผ๋ฉฐ ํ›„์ฝ”์ž”ํ‹ด ํ•จ๋Ÿ‰์€ peak area ๊ฐ’์„ ๊ธฐ์ค€์œผ๋กœ ์‚ฐ์ถœํ•˜์˜€๋‹ค. ํ•˜๊ธฐ ํ‘œ์ค€์šฉ์•ก 2์™€ ๋น„๊ตํ•˜์˜€์„ ๋•Œ ํ›„์ฝ”์ž”ํ‹ด ํ•จ๋Ÿ‰์ด ๋†’์€ ๊ฒƒ์œผ๋กœ ๋‚˜ํƒ€๋‚ฌ๊ณ , ๋‹ค๋ฅธ ์„ฑ๋ถ„๋“ค์€ ์ œ๊ฑฐ๋˜์–ด ์ˆœ๋„๊ฐ€ 90%๋กœ ๋‚˜ํƒ€๋‚ฌ๋‹ค(๋„ 1).First, standard solution 1 was stirred for 2 hours in 70% alcohol with diatoms, and then loaded into a filter bed pre-coated with diatomaceous earth, filtered and concentrated under reduced pressure. Accordingly, 1.2 g of the sample was weighed with an electronic balance and subjected to silica gel column chromatography (ฮฆ 3.5 cm x 15 cm), and as an elution solvent, N-Hexane: Acetone = 70: 30 was flowed. The separated and purified fucoxanthin was dissolved in methanol to prepare a standard solution 1 having a concentration of 0.1%. After that, standard solution 1 was dispensed in a transparent container and the content of fucoxanthin was measured by HPLC. There was no color change and fucoxanthin content was calculated based on the peak area value. When compared with the following standard solution 2, it was found that the content of fucoxanthin was high, and the other components were removed to show a purity of 90% (FIG. 1).

๋‹ค์Œ์œผ๋กœ, ํ‘œ์ค€์šฉ์•ก 2๋Š” ์žฌ๊ฒฐ์ • ๊ณต์ •์„ ํ†ตํ•˜์—ฌ ์ œ์กฐํ•˜์˜€๋‹ค. ์˜จ๋„๊ฐ€ ๋†’์€ ์šฉ๋งค์— ์šฉ์งˆ์„ ๋…น์ด๋ฉด ๋‚ฎ์€ ์˜จ๋„์—์„œ๋ณด๋‹ค ๋” ๋งŽ์€ ์–‘์˜ ์šฉ์งˆ์„ ์šฉํ•ด์‹œํ‚ฌ ์ˆ˜ ์žˆ๋‹ค. ์ด๋ ‡๊ฒŒ ์šฉํ•ด๋˜์–ด ์žˆ๋Š” ์ƒํƒœ์—์„œ, ์˜จ๋„๋ฅผ ๋‹ค์‹œ ์ฒœ์ฒœํžˆ ๋‚ด๋ฆฌ๋ฉด ์šฉํ•ด๋„๊ฐ€ ์ž‘์•„์ง€๊ธฐ ๋•Œ๋ฌธ์— ์šฉ์งˆ์€ ๋‹ค์‹œ ์„์ถœ๋˜๋ฉด์„œ ๊ฒฐ์ •์„ ์ด๋ฃจ๊ฒŒ ๋˜๋Š”๋ฐ, ์ด๋ฅผ ์žฌ๊ฒฐ์ •์ด๋ผ ํ•œ๋‹ค. ๋ณธ ๋ฐœ๋ช…์—์„œ๋Š” 70% ์ฃผ์ •์— ๊ทœ์กฐ๋ฅ˜ ์›๋ฌผ 5g์„ 2์‹œ๊ฐ„ ๋™์•ˆ ๊ต๋ฐ˜ํ•˜์—ฌ ์—ฌ๊ณผํ•œ ํ›„, ์žฌ๊ฒฐ์ • ์‹คํ—˜์„ ์œ„ํ•ด ์—ฌ๊ณผ๋œ sample์„ ์ดํ‹€๋™์•ˆ -20โ„ƒ๋ณด๊ด€ํ•˜์—ฌ ํ‘œ์ค€์šฉ์•ก 2๋ฅผ ์ œ์กฐํ•˜์˜€๋‹ค. ์ด ํ›„ ํ‘œ์ค€์šฉ์•ก 2๋ฅผ ํˆฌ๋ช…์šฉ๊ธฐ์— ๋ถ„์ฃผํ•˜๊ณ  ํ›„์ฝ”์ž”ํ‹ด ํ•จ๋Ÿ‰์„ HPLC ๋ฐฉ๋ฒ•์œผ๋กœ ์ธก์ •ํ•˜์˜€๋‹ค. ์ƒ‰๋ณ€ํ™”๋Š” ๋‚˜ํƒ€๋‚˜์ง€ ์•Š์•˜์œผ๋ฉฐ ํ›„์ฝ”์ž”ํ‹ด ํ•จ๋Ÿ‰์€ peak area ๊ฐ’์„ ๊ธฐ์ค€์œผ๋กœ ์‚ฐ์ถœํ•˜์˜€๋‹ค. ํ‘œ์ค€์šฉ์•ก 1๊ณผ ๋น„๊ตํ•˜์—ฌ, Chlorophyll ์„ฑ๋ถ„์ด ์ œ๊ฑฐ๋˜์ง€ ์•„๋‹ˆํ•˜์—ฌ ๊ฒฐ์ • sample ์€ ์ˆœ๋„๊ฐ€ 75%, ๋ชจ์•ก sample์€ ์ˆœ๋„๊ฐ€ 61%๋กœ ๋‚˜ํƒ€๋‚ฌ๋‹ค(๋„ 2, ๋„ 3).Next, standard solution 2 was prepared through a recrystallization process. Dissolving a solute in a solvent at a higher temperature can dissolve a larger amount of the solute than at a lower temperature. In this dissolved state, if the temperature is lowered again slowly, the solubility decreases, so the solute is precipitated again to form crystals, which is called recrystallization. In the present invention, after stirring and filtering 5 g of raw diatoms in 70% alcohol for 2 hours, the filtered sample for recrystallization experiment was stored at -20ยฐC for two days to prepare standard solution 2. After that, standard solution 2 was dispensed in a transparent container and the content of fucoxanthin was measured by HPLC. There was no color change and fucoxanthin content was calculated based on the peak area value. Compared with standard solution 1, the chlorophyll component was not removed, so that the crystal sample had a purity of 75%, and the mother solution sample had a purity of 61% ( FIGS. 2 and 3 ).

ํ‘œ์ค€์šฉ์•ก 3์€ ๊ทœ์กฐ๋ฅ˜ ์›๋ฌผ์— ๋Œ€ํ•œ ํƒˆ์—ผ๊ณต์ •์„ ์ถ”๊ฐ€ํ•œ ๊ฒƒ ์ด์™ธ์—๋Š” ํ‘œ์ค€์šฉ์•ก 1๊ณผ ๋™์ผํ•˜๊ฒŒ ์ง„ํ–‰ํ•˜์—ฌ ํƒˆ์—ผ๊ณต์ •์˜ ํšจ๊ณผ๋ฅผ ๊ฒ€์ฆํ•˜์˜€๋‹ค. ํ‘œ์ค€์šฉ์•ก 3์„ ํˆฌ๋ช…์šฉ๊ธฐ์— ๋ถ„์ฃผํ•˜๊ณ  ํ›„์ฝ”์ž”ํ‹ด ํ•จ๋Ÿ‰์„ HPLC ๋ฐฉ๋ฒ•์œผ๋กœ ์ธก์ •ํ•˜์˜€๋‹ค. ์ƒ‰๋ณ€ํ™”๋Š” ๋‚˜ํƒ€๋‚˜์ง€ ์•Š์•˜์œผ๋ฉฐ ํ›„์ฝ”์ž”ํ‹ด ํ•จ๋Ÿ‰์€ peak area ๊ฐ’์„ ๊ธฐ์ค€์œผ๋กœ ์‚ฐ์ถœํ•˜์˜€๋‹ค. ๊ด€์ฐฐ๋œ ํ›„์ฝ”์ž”ํ‹ด ํ•จ๋Ÿ‰์€ ํƒˆ์—ผ์„ ์ง„ํ–‰ํ•œ ๊ฒฝ์šฐ ํ‘œ์ค€์šฉ์•ก 1๊ณผ ๋น„๊ตํ•˜์—ฌ 21% ์ˆ˜์ค€์œผ๋กœ ๋‚ฎ์•„์กŒ๊ณ , ํƒˆ์—ผ์„ ์ง„ํ–‰ํ•˜์ง€ ์•Š์€ ๊ฒฝ์šฐ 17% ์ˆ˜์ค€์œผ๋กœ ๋‚ฎ์•„์กŒ๋‹ค(๋„ 4, ๋„ 5). Standard solution 3 proceeded in the same manner as standard solution 1 except for adding the desalting process for raw diatoms, and the effect of the desalting process was verified. Standard solution 3 was dispensed in a transparent container and the content of fucoxanthin was measured by HPLC. There was no color change and fucoxanthin content was calculated based on the peak area value. The observed fucoxanthin content was lowered to a level of 21% compared to standard solution 1 when desalting was performed, and was lowered to a level of 17% when desalting was not performed ( FIGS. 4 and 5 ).

๋‹ค์Œ ํ‘œ์ค€์šฉ์•ก 4๋Š” ํ›„์ฝ”์ž”ํ‹ด์ด ํ–‡๋น›์— ๋…ธ์ถœ๋œ ๊ฒฝ์šฐ์˜ ํ•จ๋Ÿ‰๋ณ€ํ™”๋ฅผ ํ†ตํ•˜์—ฌ ํ›„์ฝ”์ž”ํ‹ด์˜ ์•ˆ์ •์„ฑ์„ ๊ฒ€์ฆํ•˜์˜€๋‹ค. ํ‘œ์ค€์šฉ์•ก 4๋ฅผ ํˆฌ๋ช…์šฉ๊ธฐ์— ๋ถ„์ฃผํ•˜๊ณ  ํ›„์ฝ”์ž”ํ‹ด ํ•จ๋Ÿ‰์„ HPLC ๋ฐฉ๋ฒ•์œผ๋กœ ์ธก์ •ํ•˜์˜€๋‹ค. ์ƒ‰๋ณ€ํ™”๋Š” ๋‚˜ํƒ€๋‚˜์ง€ ์•Š์•˜์œผ๋ฉฐ ํ›„์ฝ”์ž”ํ‹ด ํ•จ๋Ÿ‰์€ peak area ๊ฐ’์„ ๊ธฐ์ค€์œผ๋กœ ์‚ฐ์ถœํ•˜์˜€๋‹ค. ์ผ์ฃผ์ผ ๋™์•ˆ ํ–‡๋น›์— ๋ฐฉ์น˜ ํ›„ ํ›„์ฝ”์ž”ํ‹ด์˜ ํ•จ๋Ÿ‰๊ณผ ์ˆœ๋„๋ฅผ ๊ด€์ฐฐํ•œ ๊ฒฐ๊ณผ ํ•จ๋Ÿ‰์€ ์•ฝ 82% ๊ฐ์†Œํ•˜์˜€๊ณ , ์ˆœ๋„๋Š” 90%์—์„œ 55%๋กœ ๊ฐ์†Œํ•˜์˜€๋‹ค(๋„ 6).The following standard solution 4 verified the stability of fucoxanthin by changing the content of fucoxanthin when exposed to sunlight. Standard solution 4 was dispensed in a transparent container and the content of fucoxanthin was measured by HPLC. There was no color change and fucoxanthin content was calculated based on the peak area value. As a result of observing the content and purity of fucoxanthin after being left in sunlight for a week, the content decreased by about 82%, and the purity decreased from 90% to 55% (FIG. 6).

๊ฒฐ๋ก ์ ์œผ๋กœ ํ›„์ฝ”์ž”ํ‹ด ์กฐ์ œ๋ฌผ์„ 0.1% ๋†๋„๋กœ ๋ฉ”ํƒ„์˜ฌ์— ์šฉํ•ดํ•œ ๊ฒƒ์„ HPLC ๋ถ„์„ํ•œ ๊ฒฐ๊ณผ ํ‘œ์ค€์šฉ์•ก 1์ด ํ•จ๋Ÿ‰๊ณผ ์ˆœ๋„๋ฉด์—์„œ ์šฐ์ˆ˜ํ•œ ๊ฒƒ์œผ๋กœ ๋‚˜ํƒ€๋‚ฌ์œผ๋ฉฐ, ์‹ค๋ฆฌ์นด ๊ฒ” ์ปฌ๋Ÿผ ํฌ๋กœ๋งˆํ† ๊ทธ๋ž˜ํ”ผ๋ฅผ ์‹ค์‹œํ•˜์ง€ ์•Š์•˜์„ ๋•Œ์—๋Š” ๋ถ„๋ฆฌ์ •์ œ๊ฐ€ ์ œ๋Œ€๋กœ ๋˜์ง€ ์•„๋‹ˆํ•˜์—ฌ ํ›„์ฝ”์ž”ํ‹ด์˜ ํ•จ๋Ÿ‰ ๋ฐ ์ˆœ๋„๊ฐ€ ๋‚ฎ์•„์ง€๋Š” ๊ฒƒ์œผ๋กœ ๋‚˜ํƒ€๋‚ฌ๋‹ค. ๋˜ํ•œ ํƒˆ์—ผ๊ณต์ •์€ ํ›„์ฝ”์ž”ํ‹ด ํ•จ๋Ÿ‰๊ณผ ์ˆœ๋„์— ํฌ๊ฒŒ ์˜ํ–ฅ์„ ๋ฏธ์น˜์ง€ ์•Š๋Š” ๊ฒƒ์œผ๋กœ ํ™•์ธ๋˜์—ˆ๊ณ , ๋˜ํ•œ ์žฌ๊ฒฐ์ • ๊ณต์ •๋„ ํ‘œ์ค€์šฉ์•ก 1๊ณผ ๋น„๊ตํ•˜์—ฌ ํ›„์ฝ”์ž”ํ‹ด์˜ ์ˆœ๋„ ๋ฐ ํ•จ๋Ÿ‰์ด ๋‹ค์†Œ ๋‚ฎ์•„์ง€๋Š” ๊ฒฐ๊ณผ๋ฅผ ํ™•์ธํ•  ์ˆ˜ ์žˆ์—ˆ๋‹ค. ๋‚˜์•„๊ฐ€ ํ›„์ฝ”์ž”ํ‹ด์€ ํ–‡๋น› ๋…ธ์ถœ์— ๋ฏผ๊ฐํ•˜๊ฒŒ ์ž‘์šฉํ•˜๋Š” ๊ฒƒ์„ ํ‘œ์ค€์šฉ์•ก 4์—์„œ ํ™•์ธํ•  ์ˆ˜ ์žˆ์—ˆ๋‹ค. In conclusion, as a result of HPLC analysis of a fucoxanthin preparation dissolved in methanol at a concentration of 0.1%, standard solution 1 was found to be excellent in content and purity. When silica gel column chromatography was not performed, separation and purification were not performed properly. Thus, it was found that the content and purity of fucoxanthin were lowered. In addition, it was confirmed that the desalting process did not significantly affect the fucoxanthin content and purity, and the recrystallization process also showed a somewhat lower purity and content of fucoxanthin compared with the standard solution 1. Furthermore, it was confirmed in Standard Solution 4 that fucoxanthin was sensitive to sunlight exposure.

์‹ค์‹œ์˜ˆ 2. ํ›„์ฝ”์ž”ํ‹ด ์ถ”์ถœ์— ์žˆ์–ด์„œ ์ ์ •์šฉ๋งค์˜ ๊ฒฐ์ •Example 2. Determination of a suitable solvent for fucoxanthin extraction

ํ›„์ฝ”์ž”ํ‹ด์˜ ๋ถ„๋ฆฌ์— ์žˆ์–ด์„œ ๋™์ข…์˜ ๋ฏธ์„ธ์กฐ๋ฅ˜ ๋ถ„๋ง์˜ ์šฉ๋งค์ถ”์ถœ์€ ์ฃผ์ •์„ ์‚ฌ์šฉํ•˜์˜€์„ ๊ฒฝ์šฐ ๊ฐ€์žฅ ์ถ”์ถœ์ˆ˜์œจ์ด ๋†’์•˜๋‹ค๋Š” ๊ฒฐ๊ณผ์™€, ์šฉ๋งค๋ฅผ ์ฃผ์ •๋กœ ํ•˜์˜€์„ ๊ฒฝ์šฐ ๊ธฐํƒ€ ์ถ”์ถœ๋ฐฉ๋ฒ•(Sohxlet๋ฒ•, ์ดˆ์ŒํŒŒ์ถ”์ถœ๋ฒ•, ์•„์ž„๊ณ„ ์ถ”์ถœ๋ฒ• ๋“ฑ)์„ ์‚ฌ์šฉํ•œ ๊ฒƒ๊ณผ ํฌ๊ฒŒ ๋‹ค๋ฅด์ง€ ์•Š์•˜๋‹ค๋Š” ๊ฒฐ๊ณผ ๋ฐ ์‹ํ’ˆ์— ํ™œ์šฉํ•  ์ˆ˜ ์žˆ๋‹ค๋Š” ์  ๋“ฑ์„ ๊ณ ๋ คํ•˜์—ฌ, 70% ์ฃผ์ •์„ ์ถ”์ถœ์šฉ๋งค๋กœ ํ•˜์˜€๋‹ค. In the separation of fucoxanthin, the solvent extraction of the same type of microalgal powder showed the highest extraction yield when alcohol was used, and other extraction methods (Sohxlet method, ultrasonic extraction method, subcritical extraction method, etc.) 70% alcohol was used as the extraction solvent in consideration of the result that it was not significantly different from the use of alcohol and the fact that it can be used in food.

๋‹ค๋งŒ, ์ถ”์ถœ์šฉ๋งค์˜ ์‚ฌ์šฉ๋Ÿ‰์€ ํ–ฅํ›„ ์‚ฐ์—…ํ™” ๊ณผ์ •์—์„œ ์ƒ์‚ฐ๋‹จ๊ฐ€ ๊ฒฐ์ •์— ์ค‘์š”ํ•œ ์š”์†Œ๊ฐ€ ๋˜๋ฏ€๋กœ ์šฐ์„  ๊ทœ์กฐ๋ฅ˜ ์›๋ฌผ ๋Œ€๋น„ ์ ์ • ์šฉ๋งค๋น„์œจ์„ ์‹คํ—˜ํ•˜์˜€๋‹ค. ๊ทœ์กฐ๋ฅ˜ ๋ถ„๋ง 100g(sample No 1, 2, 3)์— 10๋ฐฐ์˜ 70% ์ฃผ์ •์„ ๊ต๋ฐ˜ํ•˜๊ณ , 50g(No. 4, 5, 6)์— ๊ฐ๊ฐ 10๋ฐฐ, 20๋ฐฐ, 30๋ฐฐ์˜ 70% ์ฃผ์ •์„ ๊ต๋ฐ˜ํ•˜์—ฌ ์ถ”์ถœํšจ์œจ์„ ๋น„๊ตํ•˜์—ฌ ๋‚˜ํƒ€๋‚ด์—ˆ๋‹ค(ํ‘œ 1, ๋„ 7 ๋‚ด์ง€ ๋„ 9)However, since the amount of extraction solvent used is an important factor in determining the production cost in the future industrialization process, an appropriate solvent ratio compared to the raw material for diatoms was first tested. 10 times 70% alcohol was stirred in 100 g of diatom powder (sample Nos. 1, 2, 3), and 10 times, 20 times, and 30 times 70% alcohol was stirred in 50 g (No. 4, 5, 6), respectively. The extraction efficiencies were compared and shown (Table 1, FIGS. 7 to 9).

Figure PCTKR2019018529-appb-I000001
Figure PCTKR2019018529-appb-I000001

(โ€ป No.1-3; 70% ์ฃผ์ • 10x ์—ฌ์•ก, No.4; 70% ์ฃผ์ • 10x ์—ฌ์•ก, No.5; 70% ์ฃผ์ • 20x ์—ฌ์•ก, No.6; 70% ์ฃผ์ • 30x ์—ฌ์•ก)(โ€ป No.1-3; 70% alcohol 10x filtrate, No.4; 70% alcohol 10x filtrate, No.5; 70% alcohol 20x filtrate, No.6; 70% alcohol 30x filtrate)

10๋ฐฐ ์šฉ๋Ÿ‰์˜ ์ฃผ์ •๋กœ ์ถ”์ถœํ•œ ๊ตฌ๊ฐ„์—์„œ๋Š” ์ด 250mg, 20๋ฐฐ ์šฉ๋Ÿ‰์—์„œ๋Š” 274mg, 30๋ฐฐ ์šฉ๋Ÿ‰์—์„œ๋Š” 260mg์˜ ํ›„์ฝ”์ž”ํ‹ด์ด ์ถ”์ถœ๋˜์–ด ์ฃผ์ • ์–‘์ด ๋Š˜์–ด๋‚จ์— ๋”ฐ๋ผ ์ถ”์ถœํšจ์œจ์ด ์†Œํญ ์ฆ๊ฐ€ํ•˜์˜€์ง€๋งŒ ๊ทธ ์ฐจ์ด๋Š” 10% ๋‚ด์™ธ์ด๋ฏ€๋กœ ์ ์ • ์ถ”์ถœ ์šฉ๋งค๋Ÿ‰์€ 10๋ฐฐ์˜ 70% ์ฃผ์ •์„ ๊ธฐ์ค€์œผ๋กœ ์ง„ํ–‰ํ•˜์˜€๋‹ค. ๋‹ค๋งŒ, ๋”์šฑ ์ •ํ™•ํ•œ ์šฉ๋งค์กฐ๊ฑด์„ ๊ฒฐ์ •ํ•˜๊ธฐ ์œ„ํ•˜์—ฌ ์ถ”๊ฐ€์‹คํ—˜์„ ์ง„ํ–‰ํ•˜์˜€๊ณ , ๊ทธ ๊ฒฐ๊ณผ๋Š” ํ•˜๊ธฐ ์‹ค์‹œ์˜ˆ 9์— ๋‚˜ํƒ€๋‚ด์—ˆ๋‹ค. In the section extracted with 10 times the volume of alcohol, a total of 250 mg, at 20 times, 274 mg, and at 30 times, 260 mg of fucoxanthin were extracted. The extraction efficiency slightly increased as the amount of alcohol increased, but the difference was around 10%, so proper extraction The amount of solvent was carried out on the basis of 10 times 70% alcohol. However, additional experiments were conducted to determine more accurate solvent conditions, and the results are shown in Example 9 below.

์‹ค์‹œ์˜ˆ 3. ํ›„์ฝ”์ž”ํ‹ด ๋ถ„๋ฆฌ์ •์ œExample 3. Separation and purification of fucoxanthin

ํ›„์ฝ”์ž”ํ‹ด ๋“ฑ์˜ ๊ธฐ๋Šฅ์„ฑ ๋ฌผ์งˆ์˜ ๋ถ„๋ฆฌ์ •์ œ์—๋Š” ์‹ค๋ฆฌ์นด ๊ฒ” ํฌ๋กœ๋งˆํ† ๊ทธ๋ž˜ํ”ผ(silica gel chromatography)๊ฐ€ ์ด์šฉ๋˜๊ณ  ์žˆ๋Š”๋ฐ, ์—ฌ๋Ÿฌ ๊ฐ€์ง€ ํ™”ํ•ฉ๋ฌผ๋“ค์˜ ๋ฌผ๋ฆฌ ํ™”ํ•™์  ํŠน์„ฑ์— ์˜ํ•œ silica gel ์ปฌ๋Ÿผ ๋‚ด์—์„œ์˜ ์ด๋™๋„์˜ ์ฐจ์ด์— ๋”ฐ๋ผ ๋ถ„๋ฆฌ๋˜๋Š” ์„ฑ์งˆ์„ ์ด์šฉํ•œ ๊ฒƒ์ด๋‹ค. ๋ณธ ๋ฐœ๋ช…์—์„œ๋Š” ๋ชฉํ‘œ๋ฌผ์งˆ์ธ ํ›„์ฝ”์ž”ํ‹ด์„ ํšจ์œจ์ ์œผ๋กœ ๋ถ„๋ฆฌ์ •์ œํ•˜๊ธฐ ์œ„ํ•˜์—ฌ ๋‹ค์–‘ํ•œ ์กฐ๊ฑด์—์„œ์˜ ์‹ค๋ฆฌ์นด ๊ฒ” ํฌ๋กœ๋งˆํ† ๊ทธ๋ž˜ํ”ผ๋ฅผ ์ˆ˜ํ–‰ํ•˜์˜€๋‹ค.Silica gel chromatography is used for separation and purification of functional substances such as fucoxanthin. will be. In the present invention, silica gel chromatography was performed under various conditions to efficiently separate and purify fucoxanthin, a target material.

์ „์ฒด๊ณผ์ •์€ ๋„ 10์— ๋”ฐ๋ผ ๊ทœ์กฐ๋ฅ˜ ๋ถ„๋ง์— 10๋ฐฐ ์šฉ๋Ÿ‰์˜ 70% ์ฃผ์ •์„ ๋„ฃ๊ณ  2์‹œ๊ฐ„ ๊ต๋ฐ˜ ํ›„ ์—ฌ๊ณผํ•˜์—ฌ ๊ฐ๊ฐ์˜ ์ถ”์ถœ๋ฌผ์„ ์–ป๊ณ  ๋ถ„ํš๊ณผ์ •, ๋†์ถ•๊ณผ์ •์„ ๊ฑฐ์นœ ํ›„ ์‹ค๋ฆฌ์นด ๊ฒ” ํฌ๋กœ๋งˆํ† ๊ทธ๋ž˜ํ”ผ๋กœ ๋ถ„๋ฆฌํ•˜์˜€๋‹ค.As for the whole process, according to FIG. 10, 70% alcohol in a 10-fold volume was added to the diatom powder, stirred for 2 hours, filtered to obtain each extract, and fractionation process and concentration process were performed, and then separated by silica gel chromatography.

๊ตฌ์ฒด์ ์œผ๋กœ, ๋จผ์ € ๊ทœ์กฐ๋ฅ˜ ๋ถ„๋ง 100g์—์„œ 10๋ฐฐ ์šฉ๋Ÿ‰์˜ 70% ์ฃผ์ •์œผ๋กœ ์ถ”์ถœํ•œ ์ถ”์ถœ์•ก์„ 5um ์—ฌ๊ณผ์ง€๋กœ ํ•„ํ„ฐ๋งํ•˜์—ฌ ์–ป์€ 1์ฐจ ์ฃผ์ • ์ถ”์ถœ๋ฌผ์„ n-Hexane : 70% ์ฃผ์ •(1:1)๋กœ ๋ถ„๋ฆฌํ•˜์—ฌ ์•„๋ž˜์ธต์˜ 70% ์ฃผ์ • ๋ถ„ํš๋ฌผ์„ ์–ป์—ˆ๋‹ค. ์ƒ๊ธฐ ๋ถ„ํš๋ฌผ์—์„œ ํ›„์ฝ”์ž”ํ‹ด์„ ๋ถ„๋ฆฌํ•˜๊ธฐ ์œ„ํ•˜์—ฌ, ์ปฌ๋Ÿผ์— silica๋ฅผ ์ถฉ์ง„ํ•˜์—ฌ ์ƒ˜ํ”Œ์„ loadingํ•˜๊ณ , gradient (Hexane:Acetone=7:3โ†’6:4โ†’5:5โ†’Acetone) ๋ถ„๋ฆฌ๊ณผ์ •์„ ์ˆ˜ํ–‰ํ•˜์—ฌ ์ตœ์ข… ๋ถ„ํš๋ฌผ๋“ค์„ ์–ป์—ˆ๋‹ค. ์ด ํ›„, ํ›„์ฝ”์ž”ํ‹ด์„ ํฌํ•จํ•˜๊ณ  ์žˆ๋‹ค๊ณ  ์˜ˆ์ƒ๋˜์–ด์ง€๋Š” ๋ถ„ํš๋ฌผ(์ง„ํ•œ ์ฃผํ™ฉ์ƒ‰์ธต)์„ ํ™•๋ณดํ•˜์—ฌ TLC(Thin Layer Chromatography)๋ฅผ ์ˆ˜ํ–‰ํ•˜์˜€๊ณ (๋„ 11, 12), ๊ทธ ๊ฒฐ๊ณผ Fraction No.1์—์„œ No.9๊นŒ์ง€์˜ ๋ถ„ํš๋ฌผ์—์„œ ํ›„์ฝ”์ž”ํ‹ด์ด ๋ถ„๋ฆฌ๋˜์—ˆ์Œ์„ ํ™•์ธํ•˜๊ณ  ๊ณ ์••์ง„๊ณต๋†์ถ•๊ธฐ๋ฅผ ์ด์šฉํ•˜์—ฌ ๋†์ถ•๊ณผ์ •์„ ์ง„ํ–‰ํ•˜์˜€๋‹ค(๋„ 13).Specifically, the primary alcohol extract obtained by first filtering the extract extracted from 100 g of diatom powder with 70% alcohol at 10 times the volume with 5um filter paper was separated into n-Hexane: 70% alcohol (1:1), and 70% alcohol in the lower layer A fraction was obtained. In order to separate fucoxanthin from the fraction, silica was filled in a column to load a sample, and a gradient (Hexane:Acetone=7:3โ†’6:4โ†’5:5โ†’Acetone) separation process was performed to obtain final fractions. . After that, a fraction (dark orange layer) that is expected to contain fucoxanthin was obtained and TLC (Thin Layer Chromatography) was performed (FIGS. 11 and 12), and as a result, fractions from Fraction No. 1 to No. 9 It was confirmed that fucoxanthin was separated from the , and the concentration process was performed using a high pressure vacuum concentrator (FIG. 13).

์‹ค์‹œ์˜ˆ 4. HPLC๋ฅผ ์ด์šฉํ•œ ํ›„์ฝ”์ž”ํ‹ด ์ •๋Ÿ‰๋ถ„์„Example 4. Quantitative analysis of fucoxanthin using HPLC

๋จผ์ €, ํ‘œ์ค€๋ฌผ์งˆ ํ›„์ฝ”์ž”ํ‹ด(Sigma Aldrich๋กœ ๋ถ€ํ„ฐ ๊ตฌ์ž…)์„ ์ด์šฉํ•˜์—ฌ ๋†๋„๋ณ„๋กœ ํฌ์„ํ•˜์—ฌ HPLC ํ‘œ์ค€๊ฒ€๋Ÿ‰์„ ์„ ์ž‘์„ฑํ•˜์˜€๋‹ค(๋„ 14). HPLC ๋ถ„์„์€, Waters 2695 HPLC ์žฅ๋น„๋ฅผ ์‚ฌ์šฉํ•˜์˜€๊ณ , ์‚ฌ์šฉ์นผ๋Ÿผ์€ Kromasil 100-5-C18 (4.6x250mm, 5um), ๊ฒ€์ถœํŒŒ์žฅ์€ 450nm, ์šฉ๋งค๋Š” Acetonitrile / water๋ฅผ ์‚ฌ์šฉํ•˜์˜€๋‹ค(ํ‘œ 2).First, the standard material fucoxanthin (purchased from Sigma Aldrich) was diluted by concentration to prepare an HPLC standard calibration curve (FIG. 14). For HPLC analysis, Waters 2695 HPLC equipment was used, the column used was Kromasil 100-5-C18 (4.6x250mm, 5um), the detection wavelength was 450 nm, and the solvent was Acetonitrile / water (Table 2).

Figure PCTKR2019018529-appb-I000002
Figure PCTKR2019018529-appb-I000002

HPLC ์ •๋Ÿ‰๋ถ„์„๊ฒฐ๊ณผ, 100g์˜ ๊ทœ์กฐ๋ถ„๋ง์˜ 70% ์ฃผ์ • ์ถ”์ถœ๋ฌผ๋กœ๋ถ€ํ„ฐ ๋ถ„ํš/๋†์ถ•๊ณผ์ •์„ ํ†ตํ•˜์—ฌ ์ตœ์ข…์ ์œผ๋กœ ์ˆœ๋„ 60%์˜ ํ›„์ฝ”์ž”ํ‹ด 8.7g์„ ์–ป์—ˆ์œผ๋ฉฐ ๊ฒฐ๊ณผ์ ์œผ๋กœ 5.22%์˜ ์ˆ˜์œจ์„ ๋‚˜ํƒ€๋‚ด์—ˆ๋‹ค(๋„ 15).As a result of quantitative HPLC analysis, 8.7 g of fucoxanthin having a purity of 60% was finally obtained through a fractionation/concentration process from a 70% alcohol extract of 100 g of diatom powder, and as a result, a yield of 5.22% was obtained (FIG. 15).

์‹ค์‹œ์˜ˆ 5. ์žฌ๊ฒฐ์ •ํ™” ๋ฐฉ๋ฒ•์˜ ์œ ์šฉ์„ฑ ์‹คํ—˜Example 5. Utility test of recrystallization method

ํ›„์ฝ”์ž”ํ‹ด์˜ ์ •์ œ๋„ ๋ฐ ์ˆ˜์œจ์„ ํ–ฅ์ƒ์‹œํ‚ค๊ธฐ ์œ„ํ•˜์—ฌ ๋†์ถ•๋ฌผ์˜ ์žฌ๊ฒฐ์ •ํ™”์˜ ์œ ์šฉ์„ฑ์„ ๊ฒ€ํ† ํ•˜์˜€๋‹ค. ๊ตฌ์ฒด์ ์œผ๋กœ, ๊ทœ์กฐ ๋ถ„๋ง 100g์— 10๋ฐฐ ์šฉ๋Ÿ‰์˜ 70% ์ฃผ์ •๋กœ 2์‹œ๊ฐ„ ๊ต๋ฐ˜ํ•˜์—ฌ ์–ป์€ 1์ฐจ์ถ”์ถœ๋ฌผ์„, 50g์˜ ๊ทœ์กฐํ† ๋กœ ์ฝ”ํŒ…ํ•œ ์—ฌ๊ณผ๋ฒ ๋“œ์— loadingํ•˜์—ฌ ์ถ”์ถœ๋ฌผ ์—ฌ์•ก์„ ์–ป์—ˆ๋‹ค. ์ตœ์ข…์ ์œผ๋กœ ์–ป์€ ๋†์ถ•๋ฌผ์„ acetone์œผ๋กœ ์šฉํ•ด์‹œ์ผœ ์‹ค๋ฆฌ์นด ๊ฒ” ํฌ๋กœ๋งˆํ† ๊ทธ๋ž˜ํ”ผ๋กœ ํ›„์ฝ”์ž”ํ‹ด ๋ถ„ํš๋ฌผ์„ ์ƒ˜ํ”Œ๋งํ•˜๊ณ , TLC(Thin Layer Chromatography)๋กœ ์ฒดํฌํ•˜์—ฌ ํ›„์ฝ”์ž”ํ‹ด์ด ๋ถ„๋ฆฌ๋˜์—ˆ์Œ์„ ํ™•์ธํ•˜์˜€๋‹ค(๋„ 16). The usefulness of recrystallization of the concentrate to improve the degree of purification and yield of fucoxanthin was studied. Specifically, the primary extract obtained by stirring 100 g of diatomaceous powder with 70% alcohol at 10 times the volume for 2 hours was loaded into a filter bed coated with 50 g of diatomaceous earth to obtain an extract filtrate. The finally obtained concentrate was dissolved in acetone, and the fucoxanthin fraction was sampled by silica gel chromatography, and it was checked by TLC (Thin Layer Chromatography) to confirm that the fucoxanthin was separated (FIG. 16).

์ƒ๊ธฐ ํ›„์ฝ”์ž”ํ‹ด ๋ถ„ํš๋ฌผ๋กœ๋ถ€ํ„ฐ ์žฌ๊ฒฐ์ •ํ™”๋ฅผ ์‹œ๋„ํ•˜์˜€๋Š”๋ฐ, ์žฌ๊ฒฐ์ •ํ™” ๊ณผ์ •์€ ๋‹ค์Œ๊ณผ ๊ฐ™๋‹ค. ์‹œ๋ฃŒ์— ๋™๋Ÿ‰์˜ 50โ„ƒ์˜ ๋ฌผ์„ ์„ž๊ณ  40โ„ƒ์—์„œ 2์‹œ๊ฐ„ ๊ต๋ฐ˜ํ•œ ํ›„, -20โ„ƒ์—์„œ overnight ๋ณด๊ด€ํ•˜๊ณ , ์—ฌ๊ณผ๋ฅผ ํ†ตํ•ด ์žฌ๊ฒฐ์ •ํ™”๋ฅผ ์ง„ํ–‰ํ•˜์˜€๋‹ค. ํ›„์ฝ”์ž”ํ‹ด์˜ ๊ฒฐ์ •์€ ํ˜„๋ฏธ๊ฒฝ ๊ด€์ฐฐ(400๋ฐฐ์œจ)์„ ํ†ตํ•ด ํ™•์ธํ•˜์˜€์œผ๋ฉฐ(๋„ 17), ์ƒ๊ธฐ ์กฐ๊ฑด์œผ๋กœ HPLC ์ •๋Ÿ‰๋ถ„์„์„ ์ˆ˜ํ–‰ํ•˜์˜€๋‹ค(๋„ 18). ๊ทธ ๊ฒฐ๊ณผ, ์žฌ๊ฒฐ์ •ํ™”๋ฅผ ํ†ตํ•ด ํ›„์ฝ”์ž”ํ‹ด ๋†์ถ•์ด ๊ฐ€๋Šฅํ•˜๊ฒŒ ๋˜์—ˆ์ง€๋งŒ, ๋ชฉ์ ํ•˜๋Š” ๊ณ ์ˆœ๋„์˜ ํ›„์ฝ”์ž”ํ‹ด์„ ๋ถ„๋ฆฌํ•˜๋Š”๋ฐ๋Š” ์œ ์šฉ์„ฑ์ด ํฌ์ง€ ์•Š๋‹ค๋Š” ๊ฒƒ์„ ํ™•์ธํ•  ์ˆ˜ ์žˆ์—ˆ๋‹ค.Recrystallization was attempted from the fucoxanthin fraction, and the recrystallization process is as follows. The sample was mixed with the same amount of water at 50ยฐC, stirred at 40ยฐC for 2 hours, stored at -20ยฐC overnight, and recrystallized through filtration. The crystals of fucoxanthin were confirmed through microscopic observation (400 magnification) (FIG. 17), and HPLC quantitative analysis was performed under the above conditions (FIG. 18). As a result, although it was possible to concentrate fucoxanthin through recrystallization, it was confirmed that the usefulness was not great for isolating the desired high-purity fucoxanthin.

์‹ค์‹œ์˜ˆ 6. ๋‹ค์–‘ํ•œ ๋ฐฐ์–‘/ํ™˜๊ฒฝ ์กฐ๊ฑด์—์„œ์˜ ํ›„์ฝ”์ž”ํ‹ด ํ•จ๋Ÿ‰๋น„๊ตExample 6. Comparison of fucoxanthin content in various culture/environmental conditions

๊ทœ์กฐ ๋ฐฐ์–‘ํ™˜๊ฒฝ, ํ•ด์ˆ˜์—ผ ์ œ๊ฑฐ์œ ๋ฌด, ๊ฑด์กฐํ˜•ํƒœ, ๊ฑด์กฐ์˜จ๋„ ๋“ฑ์— ๋”ฐ๋ฅธ ๊ทœ์กฐ์—์„œ์˜ ํ›„์ฝ”์ž”ํ‹ด ํ•จ๋Ÿ‰๋ณ€ํ™”๋ฅผ ๋น„๊ต๋ถ„์„ ํ•˜์˜€๋‹ค(๋„ 19 ๋‚ด์ง€ 22, ํ‘œ 3).Changes in fucoxanthin content in diatoms according to the diatom culture environment, sea salt removal, drying type, drying temperature, etc. were comparatively analyzed ( FIGS. 19 to 22 , Table 3).

Figure PCTKR2019018529-appb-I000003
Figure PCTKR2019018529-appb-I000003

(โ€ป No.1; ๋ฐ”๋‹ฅ๊ทœ์กฐ/ํƒˆ์—ผX/์ž์—ฐ๊ฑด์กฐ, No.2; ๋ฐ”๋‹ฅ๊ทœ์กฐ/ํƒˆ์—ผ/60โ„ƒ๊ฑด์กฐ, No.3; ๋ถ€์ƒ๊ทœ์กฐ/ํƒˆ์—ผX/๋ƒ‰ํ•ด๋™/์ž์—ฐ๊ฑด์กฐ, No.4; ๋ถ€์ƒ๊ทœ์กฐ/ํƒˆ์—ผ/60โ„ƒ๊ฑด์กฐ, No.5; ๋ฐ”๋‹ฅ๊ทœ์กฐ/ํƒˆ์—ผ2/์ž์—ฐ๊ฑด์กฐ, No.7 ๋ถ€์ƒ๊ทœ์กฐ/40โ„ƒ์—ดํ’๊ฑด์กฐ, No.8-11; ๋ฒ ํƒ€์‚ฌ์ดํด๋กœ๋ฑ์ŠคํŠธ๋ฆฐ ์ œํ˜•๋ถ„๋ง, No.12-14; ๊ฑด์กฐ๋ถ„๋ง/1,3BG์ถ”์ถœ/10x,7x,10x, No.15; Fresh Diatom/1,3BG์ถ”์ถœ 10x, No.16; Fresh Diatom/์ฃผ์ •์ถ”์ถœ 10x)(โ€ป No.1; Bottom diatom/Desalted X/Naturally dry, No.2; Bottom Diatom/Demineralized/60โ„ƒ drying, No.3; Floating diatom/Demineralized X/Cold thaw/Naturally dry, No.4; Floating diatom /Desalting / 60โ„ƒ drying, No.5; Bottom diatom / Demineralizing 2 / Natural drying, No.7 Floating diatom / 40โ„ƒ hot air drying, No.8-11; Beta cyclodextrin formulation powder, No.12-14; Drying Powder/1,3BG Extract/10x,7x,10x, No.15; Fresh Diatom/1,3BG Extract 10x, No.16; Fresh Diatom/Alcoholic Extract 10x)

HPLC๋ถ„์„์€ ์ƒ๊ธฐ ์‹ค์‹œ์˜ˆ์™€ ๋™์ผํ•œ ์กฐ๊ฑด์œผ๋กœ ๋ถ„์„ํ•˜์˜€์œผ๋ฉฐ, ๊ทœ์กฐ๋ฅ˜ ๊ฑด์กฐ๋ถ„๋ง(No.1 ๋‚ด์ง€ No.11)์€ 50mg/mL์˜ ๋†๋„๋กœ methanol์— ์šฉํ•ด, 30๋ถ„๊ฐ„ ์ดˆ์ŒํŒŒ ์ฒ˜๋ฆฌ, filteringํ›„ ๋ถ„์„์— ์ด์šฉํ•˜์˜€์œผ๋ฉฐ, ๋ถ„์„์€ 3ํšŒ ๋ฐ˜๋ณต ์ˆ˜ํ–‰ํ•˜์˜€๋‹ค. ๊ทธ ๊ฒฐ๊ณผ, ๊ทœ์กฐ ์ƒ์œกํ™˜๊ฒฝ์— ์žˆ์–ด์„œ, ๋ฐ”๋‹ฅ๊ทœ์กฐ๊ฐ€ ๋ถ€์ƒ๊ทœ์กฐ๋ณด๋‹ค ํ›„์ฝ”์ž”ํ‹ด ํ•จ๋Ÿ‰์ด ๋†’์€ ๊ฒƒ์œผ๋กœ ๋‚˜ํƒ€๋‚ฌ์œผ๋ฉฐ (ํ‘œ 3, No.1 & No.3), ํƒˆ์—ผ์˜ ์œ ๋ฌด๋Š” ํ•จ๋Ÿ‰๋ณ€ํ™”์— ํฌ๊ฒŒ ์˜ํ–ฅ์„ ๋ฏธ์น˜์ง€ ์•Š๋Š” ๊ฒƒ์œผ๋กœ ๋‚˜ํƒ€๋‚ฌ๋‹ค.HPLC analysis was performed under the same conditions as in Example, and dry diatom powder (No. 1 to No. 11) was dissolved in methanol at a concentration of 50 mg/mL, sonicated for 30 minutes, filtered, and then used for analysis. This was repeated 3 times. As a result, in the diatom growth environment, the bottom diatom showed a higher fucoxanthin content than the floating diatom (Table 3, No. 1 & No. 3), and the presence or absence of desalination did not significantly affect the content change. appear.

ํ•œํŽธ, ๊ฑด์กฐ์˜จ๋„์— ๋”ฐ๋ฅธ ํ›„์ฝ”์ž”ํ‹ด ํ•จ๋Ÿ‰๋ณ€ํ™”๋ฅผ ๋ถ„์„ํ•œ ๊ฒฐ๊ณผ, ์ž์—ฐ๊ฑด์กฐ์— ๋น„ํ•ด ๊ฑด์กฐ์˜จ๋„๊ฐ€ 50โ„ƒ ์ด์ƒ์˜ ์กฐ๊ฑด์—์„œ๋Š” ํ›„์ฝ”์ž”ํ‹ด ํ•จ๋Ÿ‰์ด ํฌ๊ฒŒ ๊ฐ์†Œํ•˜๋Š” ๊ฒƒ์œผ๋กœ ๋‚˜ํƒ€๋‚ฌ๋‹ค (ํ‘œ 3, No.1 ๋‚ด์ง€ No.5). ์ด ๊ฒฐ๊ณผ๋Š” ํ›„์ฝ”์ž”ํ‹ด์ด ์—ด ์•ˆ์ •์„ฑ์ด ๋‚ฎ๋‹ค๋Š” ๊ธฐ์กด ์—ฐ๊ตฌ๊ฒฐ๊ณผ๋“ค๊ณผ ์ผ์น˜ํ•˜๋ฉฐ, ํ›„์ฝ”์ž”ํ‹ด์„ ์‚ฐ์—…์ ์œผ๋กœ ์ƒ์‚ฐํ•  ๊ฒฝ์šฐ 50โ„ƒ์ดํ•˜์˜ ํ™˜๊ฒฝ ๋ฐ ์ถ”์ถœ์กฐ๊ฑด์„ ์„ค์ •ํ•˜๋Š” ๊ฒƒ์ด ์ค‘์š”ํ•˜๋‹ค๋Š” ๊ฒƒ์„ ์‹œ์‚ฌํ•œ๋‹ค. On the other hand, as a result of analyzing the change in the fucoxanthin content according to the drying temperature, it was found that the fucoxanthin content was significantly reduced in the condition of the drying temperature of 50ยฐ C. or higher compared to natural drying (Table 3, No. 1 to No. 5). This result is consistent with the existing research results that fucoxanthin has low thermal stability, and suggests that it is important to set the environment and extraction conditions below 50ยฐC for industrial production of fucoxanthin.

๋ถ„์„ํ•œ ์‹œ๋ฃŒ ์ค‘ ํ›„์ฝ”์ž”ํ‹ด ํ•จ๋Ÿ‰์ด ๊ฐ€์žฅ ๋†’์€ ๊ฒƒ์€ ๊ฑด์กฐ์‹œํ‚ค์ง€ ์•Š์€ ๊ทœ์กฐ์›๋ฌผ ์‹œ๋ฃŒ๋กœ์จ, ์ด ๊ฒฐ๊ณผ๋Š” ๊ทœ์กฐ๋ฐฐ์–‘๋ฌผ์„ ์ˆ˜๊ฑฐ, ๊ฑด์กฐ(์ž์—ฐ๊ฑด์กฐ ๋˜๋Š” ์—ดํ’๊ฑด์กฐ)๊ณผ์ •์—์„œ ๊ทœ์กฐ๋‚ด์˜ ํ›„์ฝ”์ž”ํ‹ด์ด ์ผ๋ถ€ ๋ถ„ํ•ด๋˜์—ˆ๋‹ค๋Š” ๊ฒƒ์„ ๋‚˜ํƒ€๋‚ธ๋‹ค (No. 15, 16). ๊ฒฐ๋ก ์ ์œผ๋กœ, ํ›„์ฝ”์ž”ํ‹ด์˜ ๋Œ€๋Ÿ‰ ์ถ”์ถœ๊ณต์ • ํ™•๋ฆฝ์— ์žˆ์–ด์„œ ์ตœ์ดˆ๋‹จ๊ณ„์ธ ๊ทœ์กฐ์˜ ์ˆ˜ํ™•/๊ฐ€๊ณต๋‹จ๊ณ„๋Š”, ๊ฑด์กฐ๊ณต์ •์„ ๊ฑฐ์น˜์ง€ ์•Š๊ณ  ๊ทœ์กฐ ์›๋ฌผ ์ž์ฒด๋ฅผ ๊ทธ๋Œ€๋กœ ์ˆ˜ํ™•ํ•˜์—ฌ ๊ณง๋ฐ”๋กœ ์ถ”์ถœ๊ณต์ •์œผ๋กœ ์ง„์ž…ํ•˜๋Š” ๊ฒƒ์ด ๊ฐ€์žฅ ํšจ์œจ์ ์ธ ๊ณต์ •์ด๋‹ค.Among the analyzed samples, the diatomite sample that had the highest content of fucoxanthin was an undried diatomite sample. This result indicates that some of the fucoxanthin in the diatom was decomposed during the collection and drying (natural drying or hot air drying) process of the diatom culture ( No. 15, 16). In conclusion, in the first step in establishing the mass extraction process for fucoxanthin, the harvesting/processing step of diatom, it is the most efficient process to directly harvest the raw diatom without going through the drying process and directly enter the extraction process.

์‹ค์‹œ์˜ˆ 7. ํ›„์ฝ”์ž”ํ‹ด์˜ ์ œํ˜•ํ™”Example 7. Formulation of fucoxanthin

1์ฐจ ์ฃผ์ • ์ถ”์ถœ๋ฌผ์„ ์ œ์กฐํ•˜์—ฌ ์—ฌ๊ณผ ํ›„ ๋†์ถ•๊ณผ์ •์„ ๊ฑฐ์ณ ์–ป์–ด์ง„ ๋†์ถ•๋ฌผ์—, ๋ฒ ํƒ€์‚ฌ์ดํด๋กœ ๋ฑ์ŠคํŠธ๋ฆฐ์„ ๋™๋Ÿ‰ ๋ฐ 30%์”ฉ ์ฆ๊ฐ€์‹œํ‚จ ์–‘์„ ์ฒจ๊ฐ€ํ•˜์—ฌ ๋ฐ˜์ฃฝ์„ ๋งŒ๋“  ํ›„ 72์‹œ๊ฐ„ ๋™๊ฒฐ๊ฑด์กฐ๋ฅผ ์ง„ํ–‰ํ•˜์˜€๋‹ค. ๋™๊ฒฐ๊ฑด์กฐ๋œ ์‹œ๋ฃŒ๋ฅผ ๋ถ„์‡„ํ•˜์—ฌ ๋ถ„๋ง์ œํ˜•์„ ์ œ์กฐํ•˜๊ณ , ๊ฐ ์‹œ๋ฃŒ์—์„œ์˜ ํ›„์ฝ”์ž”ํ‹ด ํ•จ๋Ÿ‰์„ ๋ถ„์„ํ•˜์˜€๋‹ค (๋„ 23 ๋‚ด์ง€ 27, ํ‘œ 3 No.8 ๋‚ด์ง€ 11). ๋ถ„์„๊ฒฐ๊ณผ, ๋ฑ์ŠคํŠธ๋ฆฐ ์ฒจ๊ฐ€๋Ÿ‰์˜ ๋ณ€ํ™”์— ๋”ฐ๋ฅธ ํ›„์ฝ”์ž”ํ‹ด ํ•จ๋Ÿ‰์—๋Š” ํฐ ์ฐจ์ด๋ฅผ ๋ณด์ด์ง€ ์•Š์•˜์œผ๋ฉฐ, ํƒ€ ์‹œ๋ฃŒ๋ณด๋‹ค 5๋ฐฐ ๋†์ถ•ํ•œ ๋†์ถ•์•ก์— ๋™๋Ÿ‰์˜ ๋ฑ์ŠคํŠธ๋ฆฐ์„ ์ฒจ๊ฐ€ํ•œ ์‹œ๋ฃŒ(No.8)์—์„œ๋Š” ๊ฐ€์žฅ ๋†’์€ 316ppm (0.6%)์„ ๋‚˜ํƒ€๋‚ด์—ˆ์ง€๋งŒ ๋‹ค๋ฅธ ์‹œ๋ฃŒ์— ๋น„ํ•ด ์ƒ‰์ƒ ๋ฐ ํ–ฅ์— ์žˆ์–ด์„œ ๋ฌธ์ œ์ ์„ ๋‚˜ํƒ€๋ƒˆ๋‹ค. ๊ฒฐ๋ก ์ ์œผ๋กœ, ์‹ํ’ˆ์œผ๋กœ์˜ ์ œํ˜•์€ ๋ถ€ํ˜•์ œ์ธ ๋ฒ ํƒ€์‚ฌ์ดํด๋กœ ๋ฑ์ŠคํŠธ๋ฆฐ์„ ์ตœ์†Œ๋กœ ์ฒจ๊ฐ€ํ•˜๋Š” ์กฐ๊ฑด ์ฆ‰, ์ถ”์ถœ๋ฌผ ๋†์ถ•์•ก๊ณผ ๋™๋Ÿ‰(1:1)์˜ ๋ฑ์ŠคํŠธ๋ฆฐ์„ ์ฒจ๊ฐ€ํ•˜์—ฌ ์ œ์กฐํ•˜๋Š” ๊ฒƒ์ด ๊ฐ€์žฅ ํšจ์œจ์ ์ธ ๋ฐฉ๋ฒ•์ž„์„ ํ™•์ธํ•  ์ˆ˜ ์žˆ๋‹ค.To the concentrate obtained by preparing the primary alcohol extract, filtering and concentrating, the same amount of beta-cyclodextrin and 30% increments were added to make a dough, followed by freeze-drying for 72 hours. A powder formulation was prepared by pulverizing the freeze-dried sample, and the content of fucoxanthin in each sample was analyzed (FIGS. 23 to 27, Table 3 No. 8 to 11). As a result of the analysis, there was no significant difference in fucoxanthin content according to the change in the amount of dextrin added, and the highest 316ppm (0.6%) was obtained in the sample (No.8) in which the same amount of dextrin was added to the concentrated solution 5 times more concentrated than other samples. However, compared to other samples, it showed problems in color and smell. In conclusion, it can be confirmed that the most efficient method is to prepare the formulation for food under conditions that minimize the addition of beta-cyclodextrin as an excipient, that is, add dextrin in the same amount as the extract concentrate (1:1).

์‹ค์‹œ์˜ˆ 8. ํ”Œ๋ผ์ฆˆ๋งˆ ์ฒ˜๋ฆฌ์— ๋”ฐ๋ฅธ ํ›„์ฝ”์ž”ํ‹ด ์ถ”์ถœํšจ์œจ ๋ถ„์„Example 8. Analysis of fucoxanthin extraction efficiency according to plasma treatment

์ƒ๋ฌผ ๊ทœ์กฐ(Fresh Diatom)์—์„œ ํ›„์ฝ”์ž”ํ‹ด์„ ์ถ”์ถœํ•˜๋Š”๋ฐ ์žˆ์–ด์„œ, ํ”Œ๋ผ์ฆˆ๋งˆ ์ฒ˜๋ฆฌ ์œ ๋ฌด์— ๋”ฐ๋ฅธ ํ›„์ฝ”์ž”ํ‹ด์˜ ์ถ”์ถœํšจ์œจ์„ ๋น„๊ต ๋ถ„์„ํ•จ์œผ๋กœ์จ ์ตœ์ ์˜ ์ถ”์ถœ์กฐ๊ฑด์„ ๊ฒฐ์ •ํ•˜์˜€๋‹ค.In extracting fucoxanthin from fresh diatom, the optimal extraction conditions were determined by comparing and analyzing the extraction efficiency of fucoxanthin according to the presence or absence of plasma treatment.

๋จผ์ €, ์ƒ๋ฌผ๊ทœ์กฐ์— ํ”Œ๋ผ์ฆˆ๋งˆ๋ฅผ ์ฒ˜๋ฆฌํ•œ ๊ฒƒ๊ณผ ์ฒ˜๋ฆฌํ•˜์ง€ ์•Š์€ ์‹œ๋ฃŒ๋กœ ๋ถ€ํ„ฐ ์ถ”์ถœ๋ฌผ์„ ์กฐ์ œํ•˜์—ฌ ํ›„์ฝ”์ž”ํ‹ด ์ถ”์ถœ์ˆ˜์œจ์„ ๋น„๊ตํ•˜์˜€๋‹ค. ์ƒ๋ฌผ๊ทœ์กฐ 5g์— 20mL์˜ 70%์ฃผ์ •์„ ์ฒจ๊ฐ€ํ•˜์—ฌ 25๋ถ„๊ฐ„ plasma๋ฅผ ์ฒ˜๋ฆฌํ•œ ํ›„ 40โ„ƒ์—์„œ 3์ผ๊ฐ„ ์ถ”์ถœํ•˜๊ณ , ์ถ”์ถœ์•ก์„ 3500rpm์—์„œ 10๋ถ„๊ฐ„ ์›์‹ฌ๋ถ„๋ฆฌ ํ•˜์—ฌ ์ถ”์ถœ์ž”์‚ฌ๋ฅผ ์ œ๊ฑฐ, ์ƒ์ธต์˜ ์ถ”์ถœ์•ก์„ ์ด์šฉํ•˜์—ฌ HPLC ๋ถ„์„์„ ์ˆ˜ํ–‰ํ•˜์˜€๊ณ , ๋Œ€์กฐ๊ตฐ์œผ๋กœ์จ, ์ƒ๊ธฐ์™€ ๋™์ผํ•œ ์ถ”์ถœ์กฐ๊ฑด์—์„œ, ํ”Œ๋ผ์ฆˆ๋งˆ ์ฒ˜๋ฆฌ๋ฅผ ํ•˜์ง€ ์•Š์€ ์‹œ๋ฃŒ๋ฅผ ๋Œ€์กฐ๊ตฐ์œผ๋กœ ์„ค์ •ํ•˜์˜€๋‹ค. ์ถ”์ถœ์•ก์ด ์†Œ๋Ÿ‰์ธ ๊ด€๊ณ„๋กœ ์—ฌ๊ณผ๊ณผ์ •์„ ๊ฑฐ์น˜์ง€ ์•Š๊ณ  ์›์‹ฌ๋ถ„๋ฆฌ๋ฅผ ์ด์šฉํ•˜์—ฌ ์ž”์‚ฌ๋ฅผ์ œ๊ฑฐ ํ•œ ํ›„ ์ถ”์ถœ์•ก์„ ์–ป์—ˆ๊ณ (ํ‘œ 4), ํ”Œ๋ผ์ฆˆ๋งˆ ์ฒ˜๋ฆฌ์— ๋”ฐ๋ฅธ ํ›„์ฝ”์ž”ํ‹ด ์ถ”์ถœํšจ์œจ์„ HPLC ๋ถ„์„์„ ํ†ตํ•˜์—ฌ ๊ฒ€ํ† ํ•˜์˜€๋‹ค(ํ‘œ 5).First, extracts were prepared from samples treated with plasma and untreated biodiatoms to compare the extraction yield of fucoxanthin. After adding 20 mL of 70% alcohol to 5 g of biological diatom, plasma was treated for 25 minutes, extracted at 40 ยฐ C for 3 days, the extract was centrifuged at 3500 rpm for 10 minutes to remove the extraction residue, and HPLC analysis was performed using the extract of the upper layer. As a control, a sample that was not subjected to plasma treatment under the same extraction conditions as above was set as a control. Since the extract was small, the extract was obtained after removing the residue by centrifugation without going through a filtration process (Table 4), and the fucoxanthin extraction efficiency according to plasma treatment was reviewed through HPLC analysis (Table 5).

Figure PCTKR2019018529-appb-I000004
Figure PCTKR2019018529-appb-I000004

* NP:ํ”Œ๋ผ์ฆˆ๋งˆ ๋ฌด์ฒ˜๋ฆฌ, Pla:ํ”Œ๋ผ์ฆˆ๋งˆ ์ฒ˜๋ฆฌ * NP: no plasma treatment, Pla: plasma treatment

Figure PCTKR2019018529-appb-I000005
Figure PCTKR2019018529-appb-I000005

์ƒ๊ธฐ ํ‘œ์— ๋”ฐ๋ฅด๋ฉด, ํ”Œ๋ผ์ฆˆ๋งˆ๋ฅผ ์ฒ˜๋ฆฌํ•˜์ง€ ์•Š์€ ์‹œ๋ฃŒ์—์„œ๋Š” 1.08mg์ด ์ถ”์ถœ๋œ ๋ฐ˜๋ฉด, ํ”Œ๋ผ์ฆˆ๋งˆ๋ฅผ ์ฒ˜๋ฆฌํ•œ ์‹œ๋ฃŒ์—์„œ๋Š” 1.22mg์ด ์ถ”์ถœ๋˜์–ด, ํ”Œ๋ผ์ฆˆ๋งˆ ์ฒ˜๋ฆฌ์— ์˜ํ•ด ์•ฝ 13%์˜ ์ถ”์ถœํšจ์œจ์ด ์ฆ๊ฐ€๋˜์—ˆ์Œ์„ ํ™•์ธํ•˜์˜€๋‹ค. ์ด๋Š” ์‹œ๋ฃŒ์— ํ”Œ๋ผ์ฆˆ๋งˆ ์ฒ˜๋ฆฌ๋ฅผ ํ•จ์œผ๋กœ์จ ๊ทœ์กฐ ์„ธํฌ๋ฒฝ ์„ฑ๋ถ„์˜ ๋ฌผ์„ฑ๋ณ€ํ™”๋ฅผ ์ดˆ๋ž˜ํ•˜์—ฌ ์„ธํฌ๋‚ด ๊ตฌ์„ฑ์„ฑ๋ถ„์ด ์šฉ์ดํ•˜๊ฒŒ ์šฉ์ถœ ๋˜์—ˆ์Œ์„ ์‹œ์‚ฌํ•œ๋‹ค.According to the table, 1.08 mg was extracted from the sample not treated with plasma, whereas 1.22 mg was extracted from the sample treated with plasma, confirming that the extraction efficiency was increased by about 13% by plasma treatment. This suggests that the plasma treatment of the sample caused a change in the physical properties of the diatom cell wall components, and that the intracellular components were easily eluted.

์‹ค์‹œ์˜ˆ 9. ํ›„์ฝ”์ž”ํ‹ด ์ถ”์ถœํšจ์œจ์˜ ์ตœ์ ํ™”Example 9. Optimization of fucoxanthin extraction efficiency

์ƒ๋ฌผ ๊ทœ์กฐ(Fresh Diatom)์—์„œ ํ›„์ฝ”์ž”ํ‹ด์„ ์ถ”์ถœํ•˜๋Š”๋ฐ ์žˆ์–ด์„œ, ์‚ฌ์šฉํ•˜๋Š” ์šฉ๋งค์˜ ์ข…๋ฅ˜, ์šฉ๋งค๋Ÿ‰ ๋ฐ ์ถ”์ถœ์‹œ๊ฐ„์— ๋”ฐ๋ฅธ ์ถ”์ถœํšจ์œจ์„ ๋น„๊ต ๋ถ„์„ํ•จ์œผ๋กœ์จ ์ตœ์ ์˜ ์ถ”์ถœ์กฐ๊ฑด์„ ๊ฒฐ์ •ํ•˜์˜€๋‹ค. In extracting fucoxanthin from fresh diatom, the optimal extraction conditions were determined by comparatively analyzing the extraction efficiency according to the type of solvent used, the amount of solvent, and the extraction time.

๋จผ์ €, ์ถ”์ถœ ์šฉ๋งค์˜ ์–‘, ์‹œ๊ฐ„์— ๋”ฐ๋ฅธ ์กฐ๊ฑด์„ ๊ฒฐ์ •ํ•˜๊ธฐ ์œ„ํ•˜์—ฌ, ์‹œ๋ฃŒ๋Ÿ‰์€ ์ƒ๋ฌผ๊ทœ์กฐ 50g(No.1โˆผ18), ์ถ”์ถœ์šฉ๋งค๋Š” 70%์ฃผ์ • ๋˜๋Š” 1,3BG(Butylene Glycol)๋ฅผ ์‚ฌ์šฉํ•˜๊ณ  40โ„ƒ์กฐ๊ฑด์—์„œ, ์‹œ๋ฃŒ๋Ÿ‰ (v/v)์˜ 3๋ฐฐ, 5๋ฐฐ, 7๋ฐฐ์˜ ์šฉ๋งค๋Ÿ‰์„ ๊ฐ๊ฐ ์„ค์ •ํ•˜์—ฌ ์ถ”์ถœ (์‹œ๋ฃŒ๋ช…= ์ฃผ์ •์šฉ๋งค: A3, A5, A7. BG์šฉ๋งค: B3, B5, B7)๋กœ ํ•˜์˜€๊ณ , ์—ฌ๊ธฐ์— ์ถ”์ถœ์‹œ๊ฐ„์„ ๊ฐ๊ฐ 1์ผ, 3์ผ, 5์ผ๋กœ ์„ค์ •ํ•˜์—ฌ ์ถ”์ถœ(์‹œ๋ฃŒ๋ช…= 1์ผ: 1d, 3์ผ: 3d, 5์ผ: 5d)ํ•˜์˜€๋‹ค. First, in order to determine the amount of extraction solvent and the conditions according to time, the sample amount is 50 g of biological diatom (No. 1~18), and the extraction solvent is 70% alcohol or 1,3BG (Butylene Glycol), and , 3 times, 5 times, and 7 times the amount of the sample (v/v) was set for extraction (Sample name = Alcoholic solvent: A3, A5, A7. BG solvent: B3, B5, B7), and here The extraction time was set to 1 day, 3 days, and 5 days, respectively, and extraction was performed (sample name = 1 day: 1d, 3 days: 3d, 5 days: 5d).

์—ฌ๊ณผ ๋ฐ ์›์‹ฌ๋ถ„๋ฆฌ ๊ณผ์ •์€ ๋‹ค์Œ๊ณผ ๊ฐ™๋‹ค. ๊ฐ๊ฐ์˜ ์ถ”์ถœ์‹œ๋ฃŒ๋Š”, ์—ฌ๊ณผ์ง€ (Hyundai No.21: 8โˆผ12um, 90mm)์™€ ์ง„๊ณตํŽŒํ”„๋กœ ์—ฌ๊ณผํ•˜์—ฌ ์ž”์‚ฌ๋ฅผ ๊ฑธ๋Ÿฌ๋‚ธ ํ›„ ๋ถ„์„์— ์‚ฌ์šฉํ•˜์˜€๋‹ค(ํ‘œ 6, ๋„ 28 ๋‚ด์ง€ 47). ๋‹ค๋งŒ, BG ์ถ”์ถœ๋ฌผ์€ ์ ๋„๊ฐ€ ๋งค์šฐ ๋†’์•„ ์—ฌ๊ณผ์— 24์‹œ๊ฐ„ ์ด์ƒ ๊ฑธ๋ฆฌ๊ฒŒ ๋˜์–ด ์ถ”์ถœ์‹œ๊ฐ„ ์กฐ๊ฑด์— ๋ณ€๋™์ด ๋ฐœ์ƒํ•˜๊ฒŒ ๋˜๋ฏ€๋กœ, 3์ผ๊ณผ 5์ผ๊ฐ„ ์ถ”์ถœํ•œ ์‹œ๋ฃŒ๋Š” 3500rpm์œผ๋กœ 10๋ถ„๊ฐ„ ์›์‹ฌ๋ถ„๋ฆฌํ•œ ํ›„ ์ถ”์ถœ์•ก์„ ์–ป์—ˆ๋‹ค (No.10โˆผ12, No.16โˆผ18).Filtration and centrifugation procedures were as follows. Each extraction sample was filtered with filter paper (Hyundai No. 21: 8-12um, 90mm) and a vacuum pump to filter out residues, and then used for analysis (Table 6, FIGS. 28 to 47). However, since the BG extract has a very high viscosity, filtration takes more than 24 hours, causing variations in the extraction time conditions. Therefore, the samples extracted for 3 and 5 days were centrifuged at 3500 rpm for 10 minutes to obtain an extract (No. 10 to 12). , No. 16-18).

Figure PCTKR2019018529-appb-I000006
Figure PCTKR2019018529-appb-I000006

(* A: 70%์ฃผ์ •, B: 1,3BG, 3/5/7: 3x,5x,7x, d: day, NP:ํ”Œ๋ผ์ฆˆ๋งˆ ๋ฌด์ฒ˜๋ฆฌ, Pla:ํ”Œ๋ผ์ฆˆ๋งˆ ์ฒ˜๋ฆฌ)(* A: 70% alcohol, B: 1,3BG, 3/5/7: 3x,5x,7x, d: day, NP: no plasma treatment, Pla: plasma treatment)

Figure PCTKR2019018529-appb-I000007
Figure PCTKR2019018529-appb-I000007

(๋‹จ์œ„ : mg) (Unit: mg)

๋จผ์ €, 70% ์ฃผ์ •์„ ์šฉ๋งค๋กœ ์ถ”์ถœ์‹œ๊ฐ„์— ๋”ฐ๋ฅธ Fx ์ถ”์ถœํšจ์œจ์„ ๋ถ„์„ํ•œ ๊ฒฐ๊ณผ, 70% ์ฃผ์ • 3๋ฐฐ๋Ÿ‰(150mL) ์ถ”์ถœ์‹œ 1์ผ 13mg, 3์ผ 9mg, 5์ผ 8mg, 5๋ฐฐ๋Ÿ‰(250mL) ์ถ”์ถœ์‹œ 1์ผ 29mg, 3์ผ 23mg, 5์ผ 19mg, 7๋ฐฐ๋Ÿ‰(350mL) ์ถ”์ถœ์‹œ 1์ผ 13mg, 3์ผ 9mg, 5์ผ 8mg์œผ๋กœ ์‹œ๊ฐ„์ด ๊ฒฝ๊ณผํ•จ์— ๋”ฐ๋ผ Fx์ถ”์ถœํšจ์œจ์ด ๋‚ฎ์•„์ง€๋Š” ๊ฒƒ์œผ๋กœ ๋‚˜ํƒ€๋‚ฌ๋‹ค(ํ‘œ 7). ์ด๋กœ ๋ถ€ํ„ฐ 70% ์ฃผ์ • ์ถ”์ถœ์กฐ๊ฑด์—์„œ๋Š” ์›๋ฌผ ๋Œ€๋น„ 7๋ฐฐ(v/v)์˜ ์ฃผ์ •๋Ÿ‰์œผ๋กœ 1์ผ๊ฐ„ ์ถ”์ถœํ•˜๋Š” ๊ฒƒ์ด ๊ฐ€์žฅ ํšจ๊ณผ์ ์ด๋ผ๋Š” ๊ฒƒ์ž„์„ ์•Œ ์ˆ˜ ์žˆ๋‹ค.First, as a result of analyzing the Fx extraction efficiency according to extraction time using 70% alcohol as a solvent, when extracting 3 times 70% alcohol (150 mL), 13 mg per day, 9 mg for 3 days, 8 mg for 5 days, 1 for 5 times (250 mL) extraction It was found that the Fx extraction efficiency decreased with the passage of time at 29 mg per day, 23 mg per day, 23 mg per day, 19 mg per day, and 7-fold (350 mL), 13 mg per day, 9 mg per day, and 8 mg per day (Table 7). From this, it can be seen that in the 70% alcohol extraction condition, it is most effective to extract for one day at 7 times (v/v) the amount of alcohol compared to the original.

Figure PCTKR2019018529-appb-I000008
Figure PCTKR2019018529-appb-I000008

(๋‹จ์œ„ : mg) (Unit: mg)

๋‹ค์Œ, 1,3BG๋ฅผ ์šฉ๋งค๋กœ ์ถ”์ถœ์‹œ๊ฐ„์— ๋”ฐ๋ฅธ Fx ์ถ”์ถœํšจ์œจ์„ ๋ถ„์„ํ•œ ๊ฒฐ๊ณผ, 1,3BG 3๋ฐฐ๋Ÿ‰(150mL) ์ถ”์ถœ์‹œ 1์ผ 18mg, 3์ผ 24mg, 5์ผ 28mg, 5๋ฐฐ๋Ÿ‰(250mL) ์ถ”์ถœ์‹œ 1์ผ 32mg, 3์ผ 38mg, 5์ผ 38mg, 7๋ฐฐ๋Ÿ‰(350mL) ์ถ”์ถœ์‹œ 1์ผ 43mg, 3์ผ 45mg, 5์ผ 45mg์œผ๋กœ ์‹œ๊ฐ„์ด ๊ฒฝ๊ณผํ•จ์— ๋”ฐ๋ผ Fx์ถ”์ถœํšจ์œจ์ด ๋†’์•„์ง€๊ฑฐ๋‚˜ ๋™๋“ฑํ•œ ๊ฒƒ์œผ๋กœ ๋‚˜ํƒ€๋‚ฌ๋‹ค(ํ‘œ 8). ์ด ๊ฒฐ๊ณผ๋กœ ๋ถ€ํ„ฐ 1,3BG ์ถ”์ถœ์กฐ๊ฑด์—์„œ๋Š” ์›๋ฌผ ๋Œ€๋น„ 7๋ฐฐ(v/v)์˜ 1,3BG๋Ÿ‰์œผ๋กœ 3์ผ ๋˜๋Š” 5์ผ๊ฐ„ ์ถ”์ถœํ•˜๋Š” ๊ฒƒ์ด ํšจ๊ณผ์ ์ด๋ผ๋Š” ๊ฒƒ์ž„์„ ์•Œ ์ˆ˜ ์žˆ๋‹ค. ๊ทธ๋Ÿฌ๋‚˜, 7๋ฐฐ๋Ÿ‰์—์„œ 1์ผ๊ณผ 3์ผ, 5์ผ๊ฐ„์˜ ์ฐจ์ด๊ฐ€ 43mg๊ณผ 45mg์œผ๋กœ ํฌ์ง€ ์•Š์œผ๋ฏ€๋กœ ์‹œ๊ฐ„์  ํšจ์œจ์„ ๊ณ ๋ คํ•  ๋•Œ ์›๋ฌผ๋Œ€๋น„ 7๋ฐฐ(v/v)์˜ 1,3BG๋Ÿ‰์—์„œ 1์ผ๊ฐ„ ์ถ”์ถœํ•˜๋Š” ๊ฒƒ์ด ํšจ์œจ์ ์ด๋ผ๊ณ  ํ•  ์ˆ˜ ์žˆ๋‹ค. Next, as a result of analyzing the Fx extraction efficiency according to the extraction time with 1,3BG as a solvent, when extracting 3 times (150 mL) 1,3BG, 18 mg per day, 24 mg for 3 days, 28 mg for 5 days, 1 for 5 times (250 mL) extraction 32mg per day, 38mg 3 days, 38mg 5 days, 7 times (350mL) extraction, Fx extraction efficiency increased or equal to 43mg per day, 45mg per day, 45mg per day, and 45mg per day (Table 8). From this result, it can be seen that under the 1,3BG extraction conditions, it is effective to extract for 3 or 5 days with an amount of 1,3BG 7 times (v/v) compared to the original material. However, since the difference between 1 day, 3 days, and 5 days at 7 times the dose is 43 mg and 45 mg, it can be said that it is efficient to extract 7 times (v/v) 1,3 BG for 1 day compared to the raw material in consideration of the time efficiency. have.

Claims (8)

(S1) ๋Œ€๋Ÿ‰ ๋ฐฐ์–‘ํ•˜์—ฌ ์ˆ˜๊ฑฐ๋œ ๊ทœ์กฐ๋ฅ˜๋ฅผ 70% ์ฃผ์ •์— ๊ต๋ฐ˜ํ•˜๋Š” ๋‹จ๊ณ„;(S1) stirring the diatoms collected by mass culture in 70% alcohol; (S2) ๊ทœ์กฐํ† ๋กœ ์‚ฌ์ „์ฝ”ํŒ…(precoat)๋œ ์—ฌ๊ณผ๋ฒ ๋“œ(filter bed)์— loadingํ•˜์—ฌ ์—ฌ๊ณผํ•˜๋Š” ๋‹จ๊ณ„;(S2) loading and filtering on a filter bed pre-coated with diatomaceous earth; (S3) ์—ฌ๊ณผ๋œ ์ถ”์ถœ๋ฌผ์„ ๋ถ„ํš ๋ฐ ๋†์ถ•ํ•˜๋Š” ๋‹จ๊ณ„; (S3) fractionating and concentrating the filtered extract; (S4) ๋†์ถ•๋œ ์ถ”์ถœ๋ฌผ์—์„œ ํ›„์ฝ”์ž”ํ‹ด์„ ๋ถ„๋ฆฌ์ •์ œํ•˜๋Š” ๋‹จ๊ณ„; ๋ฐ(S4) separating and purifying fucoxanthin from the concentrated extract; and (S5) ๋ถ„๋ฆฌ์ •์ œ๋œ ํ›„์ฝ”์ž”ํ‹ด์„ ์•”์‹ค์— ๋ณด๊ด€ํ•˜๋Š” ๋‹จ๊ณ„(S5) step of storing the separated and purified fucoxanthin in a dark room ๋กœ ์ด๋ฃจ์–ด์ง€๋Š” ๊ฒƒ์„ ํŠน์ง•์œผ๋กœ ํ•˜๋Š” ๊ทœ์กฐ๋ฅ˜ ์œ ๋ž˜ ํ›„์ฝ”์ž”ํ‹ด์˜ ๋ถ„๋ฆฌ์ •์ œ๋ฐฉ๋ฒ•Separation and purification method of fucoxanthin derived from diatoms, characterized in that it consists of ์ œ1ํ•ญ์— ์žˆ์–ด์„œ, ์ƒ๊ธฐ ๊ทœ์กฐ๋ฅ˜๋Š” ์ œ์ฃผ ์šฉ์•” ํ•ด์ˆ˜์™€ ํ•จ๊ป˜ ์ทจ์ˆ˜๋˜๋Š” ๋ถ€์ฐฉ์„ฑ ๊ทœ์กฐ๋ฅ˜์ธ ๊ฒƒ์„ ํŠน์ง•์œผ๋กœ ํ•˜๋Š” ๊ทœ์กฐ๋ฅ˜ ์œ ๋ž˜ ํ›„์ฝ”์ž”ํ‹ด์˜ ๋ถ„๋ฆฌ์ •์ œ๋ฐฉ๋ฒ•.The method for separating and purifying diatoms-derived fucoxanthin according to claim 1, wherein the diatoms are adherent diatoms that are taken together with Jeju lava seawater. ์ œ2ํ•ญ์— ์žˆ์–ด์„œ, ์ƒ๊ธฐ ๋ถ€์ฐฉ์„ฑ ๊ทœ์กฐ๋ฅ˜๋Š” Melosira nummuloides, Achnanthes brevipes var. intermedia, Achnanthes sancti-pauli, Achnanthes brevipes ๋˜๋Š” Melosira octogona ๋กœ ์ด๋ฃจ์–ด์ง„ ๊ตฐ ์ค‘ ์„ ํƒ๋œ ํ•œ ์ข… ์ด์ƒ์ธ ๊ฒƒ์„ ํŠน์ง•์œผ๋กœ ํ•˜๋Š” ๊ทœ์กฐ๋ฅ˜ ์œ ๋ž˜ ํ›„์ฝ”์ž”ํ‹ด์˜ ๋ถ„๋ฆฌ์ •์ œ๋ฐฉ๋ฒ•.3. The method of claim 2, wherein the adherent diatoms are Melosira nummuloides, Achnanthes brevipes var. Intermedia, Achnanthes sancti-pauli, Achnanthes brevipes or Melosira octogona A method for separating and purifying diatom-derived fucoxanthin, characterized in that at least one selected from the group consisting of. ์ œ1ํ•ญ์— ์žˆ์–ด์„œ, ์ƒ๊ธฐ ๊ทœ์กฐ๋ฅ˜๋Š” ๋ฐ”๋‹ฅ๊ทœ์กฐ ๋ฐฐ์–‘๋ฌผ์—์„œ ์ˆ˜๊ฑฐ๋˜๋Š” ๊ทœ์กฐ๋ฅ˜์ธ ๊ฒƒ์„ ํŠน์ง•์œผ๋กœ ํ•˜๋Š” ๊ทœ์กฐ๋ฅ˜ ์œ ๋ž˜ ํ›„์ฝ”์ž”ํ‹ด์˜ ๋ถ„๋ฆฌ์ •์ œ๋ฐฉ๋ฒ•.[Claim 2] The method for separating and purifying diatoms-derived fucoxanthin according to claim 1, wherein the diatoms are diatoms collected from a bottom diatom culture. ์ œ1ํ•ญ์— ์žˆ์–ด์„œ, (S1)๋‹จ๊ณ„๋Š” ์›๋ฌผ ๋Œ€๋น„ 7๋ฐฐ(v/v)์˜ ์ฃผ์ •๋Ÿ‰์œผ๋กœ 1์ผ๊ฐ„ ์ฒ˜๋ฆฌํ•˜๋Š” ๊ฒƒ์„ ํŠน์ง•์œผ๋กœ ํ•˜๋Š” ๊ทœ์กฐ๋ฅ˜ ์œ ๋ž˜ ํ›„์ฝ”์ž”ํ‹ด์˜ ๋ถ„๋ฆฌ์ •์ œ๋ฐฉ๋ฒ•.According to claim 1, (S1) step, the separation and purification method of diatoms-derived fucoxanthin, characterized in that the treatment is 7 times (v / v) alcohol for 1 day compared to the raw material. ์ œ1ํ•ญ์— ์žˆ์–ด์„œ, (S1)๋‹จ๊ณ„์—์„œ 25๋ถ„๊ฐ„ plasma๋ฅผ ์ฒ˜๋ฆฌํ•˜๋Š” ๋‹จ๊ณ„๋ฅผ ๋” ํฌํ•จํ•˜๋Š” ๊ฒƒ์„ ํŠน์ง•์œผ๋กœ ํ•˜๋Š” ๊ทœ์กฐ๋ฅ˜ ์œ ๋ž˜ ํ›„์ฝ”์ž”ํ‹ด์˜ ๋ถ„๋ฆฌ์ •์ œ๋ฐฉ๋ฒ•.[Claim 3] The method for separating and purifying diatom-derived fucoxanthin according to claim 1, further comprising the step of treating plasma for 25 minutes in step (S1). ์ œ1ํ•ญ์— ์žˆ์–ด์„œ, (S4) ๋†์ถ•๋œ ์ถ”์ถœ๋ฌผ์—์„œ ํ›„์ฝ”์ž”ํ‹ด์„ ๋ถ„๋ฆฌ์ •์ œํ•˜๋Š” ๋‹จ๊ณ„๋Š” ์‹ค๋ฆฌ์นด ๊ฒ” ์ปฌ๋Ÿผ ํฌ๋กœ๋งˆํ† ๊ทธ๋ž˜ํ”ผ(silica gel column chromatography)์— ์˜ํ•˜์—ฌ ์ด๋ฃจ์–ด์ง€๋Š” ๊ฒƒ์„ ํŠน์ง•์œผ๋กœ ํ•˜๋Š” ๊ทœ์กฐ๋ฅ˜ ์œ ๋ž˜ ํ›„์ฝ”์ž”ํ‹ด์˜ ๋ถ„๋ฆฌ์ •์ œ๋ฐฉ๋ฒ•.The method of claim 1, wherein (S4) separating and purifying fucoxanthin from the concentrated extract is performed by silica gel column chromatography. ์ œ7ํ•ญ์— ์žˆ์–ด์„œ, ์ƒ๊ธฐ ์‹ค๋ฆฌ์นด ๊ฒ” ์ปฌ๋Ÿผ ํฌ๋กœ๋งˆํ† ๊ทธ๋ž˜ํ”ผ์— ์‚ฌ์šฉ๋˜๋Š” ์šฉ์ถœ์šฉ๋งค๋Š” N-hexane๊ณผ Acetone์˜ ๋น„์œจ์ด 7 : 3 ์ธ ๊ฒƒ์„ ํŠน์ง•์œผ๋กœ ํ•˜๋Š” ๊ทœ์กฐ๋ฅ˜ ์œ ๋ž˜ ํ›„์ฝ”์ž”ํ‹ด์˜ ๋ถ„๋ฆฌ์ •์ œ๋ฐฉ๋ฒ•.The method of claim 7, wherein the elution solvent used for the silica gel column chromatography has a ratio of N-hexane to acetone of 7:3.
PCT/KR2019/018529 2019-12-26 2019-12-26 Method for separating and purifying fucoxanthin from diatoms Ceased WO2021132764A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020190175340A KR102389503B1 (en) 2019-12-26 2019-12-26 Separation and Purification of Fucoxanthin from Diatoms
KR10-2019-0175340 2019-12-26

Publications (1)

Publication Number Publication Date
WO2021132764A1 true WO2021132764A1 (en) 2021-07-01

Family

ID=76574823

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2019/018529 Ceased WO2021132764A1 (en) 2019-12-26 2019-12-26 Method for separating and purifying fucoxanthin from diatoms

Country Status (2)

Country Link
KR (1) KR102389503B1 (en)
WO (1) WO2021132764A1 (en)

Families Citing this family (3)

* Cited by examiner, โ€  Cited by third party
Publication number Priority date Publication date Assignee Title
KR102838827B1 (en) * 2021-08-30 2025-07-28 ์žฌ๋‹จ๋ฒ•์ธ ์ œ์ฃผํ…Œํฌ๋…ธํŒŒํฌ A composition having an anti-obesity effect containing an extract of melosila nummuloides as an active ingredient
KR102838828B1 (en) * 2021-08-30 2025-07-28 ์žฌ๋‹จ๋ฒ•์ธ ์ œ์ฃผํ…Œํฌ๋…ธํŒŒํฌ Composition with anti-inflammatory effect containing extract of melosila nummuloides as an active ingredient
KR102704248B1 (en) 2024-01-15 2024-09-05 ์žฌ๋‹จ๋ฒ•์ธ ์ „๋‚จ๋ฐ”์ด์˜ค์ง„ํฅ์› Method for mass production of fucoxanthin from Ecklonia stolonifera.

Citations (5)

* Cited by examiner, โ€  Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010120939A (en) * 2008-11-17 2010-06-03 Beijing Ginko Group Biological Technology Co Ltd Method for producing fucoxanthin-containing extract
KR100964018B1 (en) * 2008-03-07 2010-06-15 ์ฃผ์‹ํšŒ์‚ฌ ์ฝ”์”จ๋“œ๋ฐ”์ด์˜คํŒœ Fermentation fucoxanthin production method and cosmetic composition containing the same
KR101818736B1 (en) * 2016-10-28 2018-01-15 ํ•œ๊ตญ๊ณผํ•™๊ธฐ์ˆ ์—ฐ๊ตฌ์› Composition for preventing or treating dihydrotestosterone-induced diseases comprising fucoxanthin
KR20180008024A (en) * 2016-07-15 2018-01-24 ์–ด์—…ํšŒ์‚ฌ๋ฒ•์ธ ์ฃผ์‹ํšŒ์‚ฌ ์ œ์ด์•ค์”จ Method for massive culture of adhesive microalgae
KR102056506B1 (en) * 2012-04-27 2019-12-16 ๊ฐ€๋ถ€์‹œํ‚ค๊ฐ€์ด์ƒค ๊ฐ€๋„ค์นด Method for producing composition containing fucoxanthin

Patent Citations (5)

* Cited by examiner, โ€  Cited by third party
Publication number Priority date Publication date Assignee Title
KR100964018B1 (en) * 2008-03-07 2010-06-15 ์ฃผ์‹ํšŒ์‚ฌ ์ฝ”์”จ๋“œ๋ฐ”์ด์˜คํŒœ Fermentation fucoxanthin production method and cosmetic composition containing the same
JP2010120939A (en) * 2008-11-17 2010-06-03 Beijing Ginko Group Biological Technology Co Ltd Method for producing fucoxanthin-containing extract
KR102056506B1 (en) * 2012-04-27 2019-12-16 ๊ฐ€๋ถ€์‹œํ‚ค๊ฐ€์ด์ƒค ๊ฐ€๋„ค์นด Method for producing composition containing fucoxanthin
KR20180008024A (en) * 2016-07-15 2018-01-24 ์–ด์—…ํšŒ์‚ฌ๋ฒ•์ธ ์ฃผ์‹ํšŒ์‚ฌ ์ œ์ด์•ค์”จ Method for massive culture of adhesive microalgae
KR101818736B1 (en) * 2016-10-28 2018-01-15 ํ•œ๊ตญ๊ณผํ•™๊ธฐ์ˆ ์—ฐ๊ตฌ์› Composition for preventing or treating dihydrotestosterone-induced diseases comprising fucoxanthin

Also Published As

Publication number Publication date
KR102389503B1 (en) 2022-04-25
KR20210082902A (en) 2021-07-06

Similar Documents

Publication Publication Date Title
WO2021132764A1 (en) Method for separating and purifying fucoxanthin from diatoms
FI70923C (en) FOERFARANDE FOER ATT SKOERDA ALGER
Stutz et al. Characterization of cytoplasmic and chloroplast polysomes in plants: Evidence for three classes of ribosomal RNA in nature
WO2021002571A1 (en) Method for mass-producing plant exosomes
CN105237430B (en) A kind of method that spicy components are extracted in the green pepper from rattan
CN1102151C (en) Method for extracting and separating filiform blue-green algae water-soluble polyose and ecto-polyose
CN105294871A (en) Preparation method and application of Enteromorpha prolifera polysaccharide with immunity enhancing function
Otte et al. Identification of the major chlorosomal bacteriochlorophylls of the green sulfur bacteria Chlorobium vibrioforme and Chlorobium phaeovibrioides; their function in lateral energy transfer
Rundberget et al. Extraction of microalgal toxins by large-scale pumping of seawater in Spain and Norway, and isolation of okadaic acid and dinophysistoxin-2
KR101055594B1 (en) Methods for massive culture of Dinophysis acuminata and isolation of pectenotoxin-2
Kabariya et al. Dairy wastewater treatment by cyanobacteria for removal of nutrients with extraction of high value compounds from biomass
CN109053720B (en) Alkaloid compound and its preparation method and use
KR940011917B1 (en) Method of extractron of panax ginseng flavonoides
JP2004075634A (en) Method for purification of fucoxanthine
Lenfant et al. Purification of immunosuppressive factors extracted from bovine spleen (lymphoid chalone)
CN1247558C (en) Isolation of taxanes
Zhou et al. Frequent antibiotic exposure stabilized the associated bacterial community while altering physiological and biochemical characteristics of the coccolithophore Chrysotila roscoffensis
CN111393470A (en) Egg yolk lecithin and preparation method thereof
CN1958580A (en) Method for extracting pacilitaxel from artificial planted south yew of whole plant
CN117903101B (en) Poly-isopentenyl phenol compound and preparation method and application thereof
CN117903098B (en) Benzyl chromone compound and preparation method and application thereof
CN105348363B (en) With the six ring triterpenoid compound and its purification methods and uses that suppress fat sedimentation
Barzkar et al. Conventional extraction methods for bioactive compounds from marine microalgae
CN116102571B (en) Separation and purification method of ocean fat-soluble toxin component in protonema reticulata
CN1264841C (en) Preparing anti-cancer active material in camptothecinum cell and method for restraining eancer cell

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19957363

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 19957363

Country of ref document: EP

Kind code of ref document: A1